Our Pathologists

Professor Jane Dahlstrom OAM
Professor Jane Dahlstrom

Executive Director, ACT Pathology, Canberra Health Services
MBBS (Hons), FPAC, PhD, FRCPA, FFOP, FFSc, Grad Cert Ed St (higher educ), SFHEA

Roles:
Anatomical Pathologist 
Senior Staff Specialist, ACT Pathology
Chair and Professor of Anatomical Pathology, Australian National University Medical School

Areas of Interest:
Breast Pathology, Perinatal Pathology, Oral Pathology, Medical Education

Contact Details:
Phone (02) 5124 2891
Fax: (02) 5124 2892

Publications:

  1. Mouse Model of Mutated in Colorectal Cancer Gene Deletion Reveals Novel Pathways in Inflammation and Cancer.
    Currey N, Jahan Z, Caldon CE, Tran PN, Benthani F, De Lacavalerie P, Roden DL, Gloss BS, Campos C, Bean EG, Bullman A, Reibe-Pal S, Dinger ME, Febbraio MA, Clarke SJ, Dahlstrom JE, Kohonen-Corish MRJ.
    Cell Mol Gastroenterol Hepatol. 2019;7(4):819-839. doi: 10.1016/j.jcmgh.2019.01.009. Epub 2019 Mar 2.
  2. Recurrence in early breast cancer: Analysis of data from 3,765 Australian women treated between 1997 and 2015.
    Stuart-Harris R, Dahlstrom JE, Gupta R, Zhang Y, Craft P, Shadbolt B.
    Breast. 2019 Apr;44:153-159. doi: 10.1016/j.breast.2019.02.004. Epub 2019 Feb 11.
  3. Of pregnancies complicated by small for gestational age babies at term, what proportions have placental findings with implications for future pregnancies or neonatal outcomes?
    Orefice R, Kent A, Sethna F, Dahlstrom JE.
    J Matern Fetal Neonatal Med. 2019 Feb 3:1-6. doi: 10.1080/14767058.2019.1566899. [Epub ahead of print]
  4. Vascular changes in fetal growth restriction: clinical relevance and future therapeutics.
    Sehgal A, Murthi P, Dahlstrom JE.
    J Perinatol. 2019 Mar;39(3):366-374. doi: 10.1038/s41372-018-0287-4. Epub 2018 Dec 5. Review.
  5. Data Set for the Reporting of Carcinomas of the Hypopharynx, Larynx, and Trachea: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.
    Helliwell T, Chernock R, Dahlstrom JE, Gale N, McHugh J, Perez-Ordoñez B, Roland N, Zidar N, Thompson LDR.
    Arch Pathol Lab Med. 2019 Apr;143(4):432-438. doi: 10.5858/arpa.2018-0419-SA. Epub 2018 Nov 30.
  6. Recurrent Chronic Intervillositis: The Diagnostic Challenge - A Case Report and Review of the Literature.
    Hannaford P, Mittal N, Sethna F, Dahlstrom JE.
    J Obstet Gynaecol Can. 2019 Mar;41(3):344-347. doi: 10.1016/j.jogc.2018.05.007. Epub 2018 Nov 7.
  7. Placental histopathology in preterm fetal growth restriction.
    Sehgal A, Dahlstrom JE, Chan Y, Allison BJ, Miller SL, Polglase GR.
    J Paediatr Child Health. 2019 May;55(5):582-587. doi: 10.1111/jpc.14251. Epub 2018 Oct 4.
  8. Optimizing poly (ADP-ribose) polymerase inhibition through combined epigenetic and immunotherapy.
    Prasanna T, Wu F, Khanna KK, Yip D, Malik L, Dahlstrom JE, Rao S.
    Cancer Sci. 2018 Nov;109(11):3383-3392. doi: 10.1111/cas.13799. Epub 2018 Oct 20. Review.
  9. Periodontal pathogens in the placenta and membranes in term and preterm birth.
    McCuaig R, Wong D, Gardiner FW, Rawlinson W, Dahlstrom JE, Robson S.
    Placenta. 2018 Aug;68:40-43. doi: 10.1016/j.placenta.2018.06.310. Epub 2018 Jun 30.
  10. IL-2 Enhances Gut Homing Potential of Human Naive Regulatory T Cells Early in Life.
    Hsu PS, Lai CL, Hu M, Santner-Nanan B, Dahlstrom JE, Lee CH, Ajmal A, Bullman A, Arbuckle S, Al Saedi A, Gacis L, Nambiar R, Williams A, Wong M, Campbell DE, Nanan R.
    J Immunol. 2018 Jun 15;200(12):3970-3980. doi: 10.4049/jimmunol.1701533. Epub 2018 May 2.
  11. Microsatellite Instability in Mouse Models of Colorectal Cancer.
    Currey N, Daniel JJ, Mladenova DN, Dahlstrom JE, Kohonen-Corish MRJ.
    Can J Gastroenterol Hepatol. 2018 Mar 1;2018:6152928. doi: 10.1155/2018/6152928. eCollection 2018.
  12. Development of the Human Fetal Kidney from Mid to Late Gestation in Male and Female Infants.
    Ryan D, Sutherland MR, Flores TJ, Kent AL, Dahlstrom JE, Puelles VG, Bertram JF, McMahon AP, Little MH, Moore L, Black MJ.
    EBioMedicine. 2018 Jan;27:275-283. doi: 10.1016/j.ebiom.2017.12.016. Epub 2017 Dec 20.
  13. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
    Boulding T, McCuaig RD, Tan A, Hardy K, Wu F, Dunn J, Kalimutho M, Sutton CR, Forwood JK, Bert AG, Goodall GJ, Malik L, Yip D, Dahlstrom JE, Zafar A, Khanna KK, Rao S.
    Sci Rep. 2018 Jan 8;8(1):73. doi: 10.1038/s41598-017-17913-x.
  14. GSTO1-1 plays a pro-inflammatory role in models of inflammation, colitis and obesity.
    Menon D, Innes A, Oakley AJ, Dahlstrom JE, Jensen LM, Brüstle A, Tummala P, Rooke M, Casarotto MG, Baell JB, Nguyen N, Xie Y, Cuellar M, Strasser J, Dahlin JL, Walters MA, Burgio G, O'Neill LAJ, Board PG.
    Sci Rep. 2017 Dec 19;7(1):17832. doi: 10.1038/s41598-017-17861-6.
  15. Classification of causes and associated conditions for stillbirths and neonatal deaths.
    International Stillbirth Alliance Collaborative for Improving Classification of Perinatal Deaths, Flenady V, Wojcieszek AM, Ellwood D, Leisher SH, Erwich JJHM, Draper ES, McClure EM, Reinebrant HE, Oats J, McCowan L, Kent AL, Gardener G, Gordon A, Tudehope D, Siassakos D, Storey C, Zuccollo J, Dahlstrom JE, Gold KJ, Gordijn S, Pettersson K, Masson V, Pattinson R, Gardosi J, Khong TY, Frøen JF, Silver RM.
    Semin Fetal Neonatal Med. 2017 Jun;22(3):176-185. doi: 10.1016/j.siny.2017.02.009. Epub 2017 Mar 9. Review.
  16. Current topics in breast pathology: expert perspectives.
    Dahlstrom JE, Rakha EA, Lakhani SR, Schnitt SJ.
    Pathology. 2017 Feb;49(2):109-110. doi: 10.1016/j.pathol.2016.12.001. Epub 2017 Jan 6. No abstract available.
  17. The biological and clinical significance of stromal-epithelial interactions in breast cancer.
    McCuaig R, Wu F, Dunn J, Rao S, Dahlstrom JE.
    Pathology. 2017 Feb;49(2):133-140. doi: 10.1016/j.pathol.2016.10.009. Epub 2016 Dec 29. Review.
  18. Dichloroacetate Prevents Cisplatin-Induced Nephrotoxicity without Compromising Cisplatin Anticancer Properties.
    Galgamuwa R, Hardy K, Dahlstrom JE, Blackburn AC, Wium E, Rooke M, Cappello JY, Tummala P, Patel HR, Chuah A, Tian L, McMorrow L, Board PG, Theodoratos A.
    J Am Soc Nephrol. 2016 Nov;27(11):3331-3344. Epub 2016 Mar 9.
  19. Significance of mast cell distribution in placental tissue and membranes in spontaneous preterm birth.
    Needham K, Fadia M, Dahlstrom JE, Harrington K, Shadbolt B, Robson SJ.
    J Inflamm Res. 2016 Jul 8;9:141-5. doi: 10.2147/JIR.S80722. eCollection 2016.
  20. Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes.
    Dooley J, Tian L, Schonefeldt S, Delghingaro-Augusto V, Garcia-Perez JE, Pasciuto E, Di Marino D, Carr EJ, Oskolkov N, Lyssenko V, Franckaert D, Lagou V, Overbergh L, Vandenbussche J, Allemeersch J, Chabot-Roy G, Dahlstrom JE, Laybutt DR, Petrovsky N, Socha L, Gevaert K, Jetten AM, Lambrechts D, Linterman MA, Goodnow CC, Nolan CJ, Lesage S, Schlenner SM, Liston A.
    Nat Genet. 2016 May;48(5):519-27. doi: 10.1038/ng.3531. Epub 2016 Mar 21.
  21. Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer.
    Boulding T, Wu F, McCuaig R, Dunn J, Sutton CR, Hardy K, Tu W, Bullman A, Yip D, Dahlstrom JE, Rao S.
    PLoS One. 2016 Feb 9;11(2):e0148065. doi: 10.1371/journal.pone.0148065. eCollection 2016.
  22. Placental involvement by non-Hodgkin lymphoma in a Crohn disease patient on long-term thiopurine therapy.
    Chen G, Crispin P, Cherian M, Dahlstrom JE, Sethna FF, Kaye G, Pavli P, Subramaniam K.
    Intern Med J. 2016 Jan;46(1):102-5. doi: 10.1111/imj.12957.
  23. Stillbirths: recall to action in high-income countries.
    Flenady V, Wojcieszek AM, Middleton P, Ellwood D, Erwich JJ, Coory M, Khong TY, Silver RM, Smith GC, Boyle FM, Lawn JE, Blencowe H, Leisher SH, Gross MM, Horey D, Farrales L, Bloomfield F, McCowan L, Brown SJ, Joseph KS, Zeitlin J, Reinebrant HE, Ravaldi C, Vannacci A, Cassidy J, Cassidy P, Farquhar C, Wallace E, Siassakos D, Heazell AE, Storey C, Sadler L, Petersen S, Frøen JF, Goldenberg RL; Lancet Ending Preventable Stillbirths study group; Lancet Stillbirths In High-Income Countries Investigator Group.
    Lancet. 2016 Feb 13;387(10019):691-702. doi: 10.1016/S0140-6736(15)01020-X. Epub 2016 Jan 19. Review.
  24. Activation of LINE-1 Retrotransposon Increases the Risk of Epithelial-Mesenchymal Transition and Metastasis in Epithelial Cancer.
    Rangasamy D, Lenka N, Ohms S, Dahlstrom JE, Blackburn AC, Board PG.
    Curr Mol Med. 2015;15(7):588-97. Review.
  25. HIF1α deficiency reduces inflammation in a mouse model of proximal colon cancer.
    Mladenova DN, Dahlstrom JE, Tran PN, Benthani F, Bean EG, Ng I, Pangon L, Currey N, Kohonen-Corish MR.
    Dis Model Mech. 2015 Sep;8(9):1093-103. doi: 10.1242/dmm.019000. Epub 2015 Jul 16.
  26. The effect of pregnancy-induced hypertensive disorders on placental growth along short and long axes and neonatal outcomes.
    Phad N, Dahlstrom JE, Ellwood D, Kent AL.
    Aust N Z J Obstet Gynaecol. 2015 Jun;55(3):239-44. doi: 10.1111/ajo.12308. Epub 2015 Jun 5.
  27. A safety and feasibility study of the use of 670 nm red light in premature neonates.
    Kent AL, Broom M, Parr V, Essex RW, Abdel-Latif ME, Dahlstrom JE, Valter K, Provis J, Natoli R.
    J Perinatol. 2015 Jul;35(7):493-6. doi: 10.1038/jp.2015.5. Epub 2015 Feb 19.
Associate Professor Sanjiv Jain
Associate Professor Sanjiv Jain

Director of Anatomical Pathology
MBBS FRCPA

Roles:
Anatomical Pathologist 
Senior Staff Specialist, ACT Pathology
Clinical Associate Professor, Australian National University Medical School

Area of Interest:
Breast Pathology, Soft Tissue Pathology, Renal Pathology, Gastrointestinal Pathology

Contact details:
Telephone: (02) 5124 2869
Fax: (02) 5124 2892

Recent publications:

  1. Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma.
    Cui Q, Vari F, Cristino AS, Salomon C, Rice GE, Sabdia MB, Guanzon D, Palma C, Mathew M, Talaulikar D, Jain S, Han E, Hertzberg MS, Gould C, Crooks P, Thillaiyampalam G, Keane C, Gandhi MK.
    Oncotarget. 2018 Oct 5;9(78):34644-34657. doi: 10.18632/oncotarget.26141. eCollection 2018 Oct 5.
  2. A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival.
    Keane C, Tobin J, Talaulikar D, Green M, Crooks P, Jain S, Gandhi M.
    Oncotarget. 2018 May 4;9(34):23620-23627. doi: 10.18632/oncotarget.25306. eCollection 2018 May 4.
  3. Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.
    Vari F, Arpon D, Keane C, Hertzberg MS, Talaulikar D, Jain S, Cui Q, Han E, Tobin J, Bird R, Cross D, Hernandez A, Gould C, Birch S, Gandhi MK.
    Blood. 2018 Apr 19;131(16):1809-1819. doi: 10.1182/blood-2017-07-796342. Epub 2018 Feb 15.
  4. Massive fatal pulmonary haemorrhage during bevacizumab treatment following microwave ablation therapy for oligometastatic lung metastasis from rectal cancer.
    Prasanna T, Briggs G, Jain S, Yip D.
    Interact Cardiovasc Thorac Surg. 2018 Mar 1;26(3):514-515. doi: 10.1093/icvts/ivx342.
  5. The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma.
    Keane C, Gould C, Jones K, Hamm D, Talaulikar D, Ellis J, Vari F, Birch S, Han E, Wood P, Le-Cao KA, Green MR, Crooks P, Jain S, Tobin J, Steptoe RJ, Gandhi MK.
    Clin Cancer Res. 2017 Apr 1;23(7):1820-1828. doi: 10.1158/1078-0432.CCR-16-1576. Epub 2016 Sep 20.
  6. Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.
    Keane C, Vari F, Hertzberg M, Cao KA, Green MR, Han E, Seymour JF, Hicks RJ, Gill D, Crooks P, Gould C, Jones K, Griffiths LR, Talaulikar D, Jain S, Tobin J, Gandhi MK.
    Lancet Haematol. 2015 Oct;2(10):e445-55. doi: 10.1016/S2352-3026(15)00150-7. Epub 2015 Oct 1.
  7. Visualization of Nerve Fiber Orientations in the Human Optic Chiasm Using Photomicrographic Image Analysis.
    Jain NS, Jain SV, Wang X, Neely AJ, Tahtali M, Jain S, Lueck CJ.
    Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6734-9. doi: 10.1167/iovs.15-17443.
  8. Increasing incidence of glioblastoma multiforme and meningioma, and decreasing incidence of Schwannoma (2000-2008): Findings of a multicenter Australian study.
    Dobes M, Khurana VG, Shadbolt B, Jain S, Smith SF, Smee R, Dexter M, Cook R.
    Surg Neurol Int. 2011;2:176. doi: 10.4103/2152-7806.90696. Epub 2011 Dec 13.
  9. A multicenter study of primary brain tumor incidence in Australia (2000-2008).
    Dobes M, Shadbolt B, Khurana VG, Jain S, Smith SF, Smee R, Dexter M, Cook R.
    Neuro Oncol. 2011 Jul;13(7):783-90. doi: 10.1093/neuonc/nor052.
Dr Huw Llewellyn

Director of Cytopathology
MBBS BSc(Hons) FRCS FRCPA

Roles:
Anatomical Pathologist 
Senior Staff Specialist, ACT Pathology 

Areas of Interest:
Breast Pathology
Cytopathology
Gastrointestinal Pathology
Surgical Pathology
Quality Assurance

Contact Details:
Phone (02) 5124 2882
Fax (02) 5124 2892

Dr Maya Cherian
Dr Maya Cherian

Anatomical Pathology
MBBS MD FRCPA

Roles: 
Anatomical Pathologist 
Senior Staff Specialist, ACT Pathology 

Areas of Interest:
Gastrointestinal Pathology
Renal Pathology

Contact Details:
Phone (02) 5124 2865
Fax (02) 5124 2892

Dr Michael Brown

Anatomical Pathology
BMedSc MBBS (UNSW) FRCPA

Roles: 
Anatomical Pathologist 
Senior Staff Specialist, ACT Pathology

Areas of Interest:
Anatomical Pathology
Cytopathology

Contact Details:
Phone (02) 5124 2866
Fax (02) 5124 2892

Dr Genevieve Bennett

Anatomical Pathology
MBBS FRCPA

Roles: 
Anatomical Pathologist 
Senior Staff Specialist, ACT Pathology

Areas of Interest:
Skin pathology
Breast Pathology
Fine Needle Aspiration Cytology (FNAC)

Contact details:
Phone (02) 5124 2868
Fax (02) 5124 2892

Dr Alex Currie

Anatomical Pathology
BHB MBChB FRCPA GradCert TertiaryEd

Roles: 
Anatomical Pathologist 
Staff Specialist, ACT Pathology
Lecturer, Australian National University Medical School

Areas of Interest: 
Head and Neck Pathology
Medical education
Molecular Pathology
Uropathology

Contact Details:
Phone (02) 5124 5222
Fax (02) 5124 2892

Dr Mitali Fadia
Dr Mitali Fadia

Anatomical Pathology
MBBS MD FRCPA

Roles: 
Anatomical Pathologist 
Senior Staff Specialist, ACT Pathology
Senior Lecturer, Australian National University Medical School

Areas of Interest: 
Perinatal Pathology
Renal Pathology
GIT Pathology and Neuropathology

Contact Details
Phone (02) 5124 2880
Fax (02) 5124 2892

Publications:

  1. Post-colonoscopy colorectal cancers identified by probabilistic and deterministic linkage: results in an Australian prospective cohort.
    Subramaniam K, Ang PW, Neeman T, Fadia M, Taupin D. BMJ Open. 2019 Jun 21; 9(6)
  2. Crizotinib and surgery for long term disease control in children and adolescents with ALK-positive inflammatory myofibroblastic tumours.
    Trahair T, Fadia M, Mackenzie K et el. JCO precision Oncology May 2019
  3. Prognostic Utility of CDX2 and PD-L1 in Rectal Cancer.
    Shahnam A, Paver E, Nguyen B, Fadia M, Ali S. Appl Immunohistochem Mol Morphol. 2019 Jun 3
  4. PD-L1 expression associated with worse survival outcome in malignant pleural mesothelioma.
    Nguyen BH, Montgomery R, Fadia M, Wang J, Ali S. Asia Pac J Clin Oncol. 2018 Feb; 14(1):69-73
  5. Reamed locked intramedullary nailing for studying femur fracture and its complication.
    Yoshino O, Brady J, Woodford, P, Fadia M, Balogh ZJ et el. European cells and material 2017; vol 34: 99-107
  6. MMP2 and MMP9 associate with crescentic glomerulonephritis.
    Phillips TM, Fadia M, Lea-Henry TN, Smiles J, Walters GD, Jiang SH. Clin Kidney J. 2017 Apr;10(2):215-220.
  7. Universal molecular screening does not effectively detect Lynch syndrome in clinical practice.
    Brennan B, Hemmings CT, Clark I, Yip D, Fadia M, Taupin DR. Therap Adv Gastroenterol. 2017 Apr; 10(4):361-371.
  8. Significance of mast cell distribution in placental tissue and membranes in spontaneous preterm birth.
    Needham K, Fadia M, Dahlstrom JE, Harrington K, Shadbolt B, Robson SJ. J Inflamm Res. 2016 Jul 8; 9:141-5.
Associate Professor Adrienne Morey
Associate Professor Adrienne Morey

Director Diagnostic Genomics
BSc(Med)(Hons) MBBS(Hons) DPhil(Oxon) FRCPA

Roles:
Anatomical Pathologist
Senior Staff Specialist, Anatomical Pathology, ACT Pathology
Deputy Director, Anatomical Pathology, ACT Pathology
Associate Professor, Australian National University Medical School

Areas of Interest:
Haematopathology
Neuropathology
Dermatopathology
Applications of Molecular Pathology

Contact Details:
Phone (02) 5124 8350
Fax (02) 5124 2892

Recent publications:

  1. Farshid G, Bilous M, Morey A, Fox S, Lakhani S, Loi S, Bell R, Spillane A (2019) ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia. Pathology, 51(4): 345-48
  2. Rivalland G, Mitchell P, Murone C, Asadi K, Morey AL, Starmans M, Boutros PC, Walkiewicz M, Solomon B, Wright G, Knight S, John T (2019). Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort. Translational Lung Cancer Research, 8(2):167-175. doi: 10.21037/tlcr.2019.03.11
  3. Randhawa M, Archer C, Gaughan G, Miller A, Morey A, Dua D, Yip D (2019) Combined immunotherapy grade IV dermatitis in metastatic melanoma. Asia-Pacific Journal of Clinical Oncology, 2019 published online 27th February 2019 DOI:10.1111/ajco.13136
  4. Deenick E, Morey A, Danta ,  Emmett L, Fay K, Gracie G, Macintosh R, Smith S, Sasson S, Sewell W, Cowley M, Tangye S, Kelleher A, CIRCA Consortium, Phan T (2018) Reversible suppression of lymphoproliferation and thrombocytopenia with rapamycin in a patient with common variable immunodeficiency. Journal of Clinical Immunology, published online 19th Jan 2018. https://doi.org/10.1007/s10875-018-0477-z
  5. Kumarasinghe P, Morey A, Bilous M, Farshid G, Francis G, Lampe G, McCue G, von Neumann-Cosel V, Fox S (2017) HER2 testing in advanced gastric and gastro-oesophageal cancer; analysis of an Australia-wide testing program. Pathology, 49(6): 575-581 http://dx/doi.org/10.1016/j.pathol.2017.05.009 [Pathology “Article of the Year Award, 2017]
  6. Morey A, Brown B, Farshid G, Fox S, Francis G, McCue G, von Neumann-Cosel V, Bilous M (2016) Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridization program. Pathology, 43(6): 535-542. Online publication: 25-AUG-2016 DOI: 10.1016/j.pathol.2016.05.007
  7. Chia PL, Do H, Morey A, Mitchell P, Dobrovic A, John T (2016) Temporal changes of EGFR mutation and T790M levels in tumour and plasma DNA following AZD9291 treatment. Lung Cancer, 98: 29-32 (doi: 10.1016/j.lungcan. 2016.05.003. Epub 2016 May 11)
  8. Crossley K, Agnihoti S, Chaganti J, Rodriguez M, McNally LP, Venna N, Turbett S, Gutman M, Morey A, Koralnik IJ, Brew BJ (2016) Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals.  Journal of NeuroVirology, 22(4): 541-5  (doi: 10.1007/s13365-015-0419-y. Epub 2016 Jan 4.)
  9. Nagaraja V, Shaw N, Morey AL, Cox MR, Eslick GD (2016). HER2 expression in oesophageal carcinoma and Barrett’s oesophagus associated adenocarcinoma: an Australian Study. European Journal of Surgical Oncology, 42(1):140-8 (epub Sept 10, 2015: DOI: http://dx.doi.org/10.1016/j.ejso.2015.08.159)
  10. Selinger T, Cooper W, Lum T, McNeil C, Morey A, Waring P, Amanuel B, Millward M, Peverall J, Van Vliet B, Christie M, Tran Y, Diakos C, Pavlakis, N, Gill A, O’Toole S (2015) Equivocal ALK FISH cases may benefit from ancillary FISH probe testing. Histopathology, 67(5):654-63. (doi: 10.1111/his.12708. Epub 2015 May 24)
  11. Chantrill A, Nagrial A, Watson C, Johns A, Martyn-Smith M, Simpson S, Mead S, Jones M, Samra J, Gill A, Watson N, Chin V, Humphris J, Chou A, Brown B, Morey A, Pajic M, Grimmond S, Chang D, Thomas D, Sebastian L, Sjoquist K, Yip S, Pavlakis N, Asghari R, Harvey S, Grimson P, Simes J, Biankin A (2015) Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer therapy (IMPaCT) trial. Clinical Cancer Research, 21(9):2029-37.doi: 10.1158/1078-0432.CCR-15-0426. 
  12. Nair R, Roden DL, Teo WS, McFarland A, Junankar S, Ye S, Nguyen A, Yang J, Nikolic I, Hui M, Morey A, Shah J, Pfefferle AD, Usary J, Selinger C, Baker LA, Armstrong N, Cowley MJ, Naylor MJ, Ormandy CJ, Lakhani S, Herschkowitz JI , Perou CM, Kaplan W, O’Toole SA, Swarbrick A (2014) c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer. Oncogene 2013 Sept 23 doi 1038/onc.2013.368, Oncogene 2014, 33(30):3992-4002. 
  13. Huang C, Kim L, Winder M, Morey A, Winder M (2015) Intraosseous lipomatous meningioma. Case Reports in Neurological Medicine, vol. 2015, Article ID 482140. doi:10.1155/2015/482140. Epub 2015 Jan 26.
    http://www.hindawi.com/journals/crinm/2015/482140/ 
  14. Toogood V, Samaras K, Milliken S, Morey A (2014) Adrenal tumours - How to establish malignancy. BMJ Case Reports, Dec 23 2014. pii: bcr2014203736. doi: 10.1136/bcr-2014-203736.
  15. Cummings MC, Simpson PT, Reid LE, Jayanthan J, Skerman J, Song S, McCart Reed AE, Kutasovic JR, Morey AL, Marquart L, O'Rourke P, Lakhani SR (2014) Metastatic progression of breast cancer: insights from 50 years of autopsies. J Pathol, 232(1): 23-31. 
  16. Houang M, Toon CW, Clarkson A, Sioson L, Watson N, Farzin M, Selinger CI, Chou A, Morey AL, Cooper WA, O'Toole AS, Gill AJ (2014) Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer. Pathology, 46(5): 383-388. 
  17. Cooper W, Fox S, O’Toole S, Morey A, Francis G, Pavlakis N, O’Byrne K, Dettrick A, Leong T, Rathi V, Spagnolo D, Hemmings C, Singh M, Moffat D, Tsao M, Wilner K, Buller R, Pitman-Lowenthal S, Arifeen S, Binko J, Alam M (2014) National Working Group Meeting on ALK diagnostic in lung cancer. Asia Pacific Journal of Clinical Oncology, 10 (S2); 11-17. DOI: 10.1111/ajco.12190
Associate Professor Peter Hickman

Director of Chemical Pathology
MBBS PhD FRCPA MHA

Roles:
Chemical Pathologist 
Associate Professor, Australian National University
Associate Editor, Clinical Biochemistry

Areas of Interest:
Cardiac Markers
Endocrinology.

Contact:
Phone (02) 5124 2840
Fax (02) 5124 3398

Recent publications:

  1. Age-related differences in hs-cTnI concentration in healthy adults.
    Hickman PE, Abhayaratna WP, Potter JM, Koerbin G.
    Clin Biochem. 2019 Apr 25. pii: S0009-9120(19)30211-5. doi: 10.1016/j.clinbiochem.2019.04.014. [Epub ahead of print]
    PMID: 31028731
  2. Are the changes in diagnostic criteria for gestational diabetes mellitus reflected in perinatal outcomes? A retrospective assessment.
    Ehmann DMT, Hickman PE, Potter JM.
    Aust N Z J Obstet Gynaecol. 2019 Feb 27. doi: 10.1111/ajo.12956. [Epub ahead of print]
    PMID: 30811589
  3. The importance of low level QC for high sensitivity troponin assays.
    Hickman PE, Koerbin G, Badrick T, Oakman C, Potter JM.
    Clin Biochem. 2018 Aug;58:60-63. doi: 10.1016/j.clinbiochem.2018.05.007. Epub 2018 May 8.
    PMID: 29750940
  4. The investigation of interferences in immunoassay.
    Ward G, Simpson A, Boscato L, Hickman PE.
    Clin Biochem. 2017 Dec;50(18):1306-1311. doi: 10.1016/j.clinbiochem.2017.08.015. Epub 2017 Aug 26. Review.
    PMID: 28847718
  5. 'Aussie Normals': an a priori study to develop reference intervals in a healthy Australian population using the Beckman Coulter LH 750 Haematology Analyser as candidates for harmonised values.
    Koerbin G, Potter JM, Andriolo K, West NP, Glasgow N, Hawkins C, Cavanaugh JA, Hickman PE.
    Pathology. 2017 Aug;49(5):518-525. doi: 10.1016/j.pathol.2017.04.003. Epub 2017 Jul 10.
    PMID: 28705348
  6. Reassessment of lipaemic index threshold triggering high speed centrifugation of lipaemic specimens.
    Salib MM, Oakman C, Simpson AJ, Hickman PE, Potter JM.
    Pathology. 2017 Jun;49(4):423-424. doi: 10.1016/j.pathol.2016.12.352. Epub 2017 Apr 24. No abstract available. 
    PMID: 28446363
  7. The relationship of plasma creatinine (as eGFR) and high-sensitivity cardiac troponin and NT-proBNP concentrations in a hospital and community outpatient population.
    Potter JM, Simpson AJ, Kerrigan J, Southcott E, Salib MM, Koerbin G, Hickman PE.
    Clin Biochem. 2017 Oct;50(15):813-815. doi: 10.1016/j.clinbiochem.2017.04.003. Epub 2017 Apr 6.
    PMID: 28392226
  8. Statistical considerations for determining high-sensitivity cardiac troponin reference intervals.
    Hickman PE, Koerbin G, Potter JM, Abhayaratna WP.
    Clin Biochem. 2017 Jun;50(9):502-505. doi: 10.1016/j.clinbiochem.2017.02.022. Epub 2017 Mar 3.
    PMID: 28263716
  9. Harmonising Reference Intervals for Three Calculated Parameters used in Clinical Chemistry.
    Hughes D, Koerbin G, Potter JM, Glasgow N, West N, Abhayaratna WP, Cavanaugh J, Armbruster D, Hickman PE.
    Clin Biochem Rev. 2016 Aug;37(3):105-111. Review.
    PMID: 27872504
  10. Cross-sectional study of high-sensitivity cardiac troponins T and I in a hospital and community outpatient setting.
    Potter JM, Simpson AJ, Kerrigan J, Southcott E, Salib MM, Koerbin G, Hickman PE.
    Clin Biochem. 2017 Feb;50(3):105-109. doi: 10.1016/j.clinbiochem.2016.10.011. Epub 2016 Oct 22.
    PMID: 27780745
  11. Reality check for cardiac troponin testing - Sometimes the result is wrong.
    Kavsak PA, Saenger AK, Hickman PE.
    Clin Biochem. 2016 Oct;49(15):1107-1108. doi: 10.1016/j.clinbiochem.2016.09.007. Epub 2016 Sep 17. No abstract available. 
    PMID: 27645499
  12. Statistical issues with the determination of the troponin 99th percentile - Not just a problem for troponin?
    Hickman PE, Koerbin G, Saenger AK, Kavsak PA.
    Clin Biochem. 2016 Oct;49(15):1105-1106. doi: 10.1016/j.clinbiochem.2016.09.013. Epub 2016 Sep 13. No abstract available. 
    PMID: 27637295
  13. Using a thyroid disease-free population to define the reference interval for TSH and free T4 on the Abbott Architect analyser.
    Hickman PE, Koerbin G, Simpson A, Potter JM, Hughes DG, Abhayaratna WP, West N, Glasgow N, Armbruster D, Cavanaugh J, Reed M.
    Clin Endocrinol (Oxf). 2017 Jan;86(1):108-112. doi: 10.1111/cen.13143. Epub 2016 Jul 21.
    PMID: 27333057
  14. Retrospective reassessment of gestational diabetes mellitus diagnosis by using the new classification.
    Salib MM, Hickman PE, Oakman C, Potter JM.
    Pathology. 2015 Jun;47(4):391-2. doi: 10.1097/PAT.0000000000000259. No abstract available. 
    PMID: 25938356
  15. Multiple biomarkers including cardiac troponins T and I measured by high-sensitivity assays, as predictors of long-term mortality in patients with chronic renal failure who underwent dialysis.
    Hickman PE, McGill D, Potter JM, Koerbin G, Apple FS, Talaulikar G.
    Am J Cardiol. 2015 Jun 1;115(11):1601-6. doi: 10.1016/j.amjcard.2015.02.066. Epub 2015 Mar 14.
    PMID: 25851798
  16. Bias Assessment of General Chemistry Analytes using Commutable Samples.
    Koerbin G, Tate JR, Ryan J, Jones GR, Sikaris KA, Kanowski D, Reed M, Gill J, Koumantakis G, Yen T, St John A, Hickman PE, Simpson A, Graham P.
    Clin Biochem Rev. 2014 Nov;35(4):203-11. Review.
    PMID: 25678726
  17. 'Aussie normals': an a priori study to develop clinical chemistry reference intervals in a healthy Australian population.
    Koerbin G, Cavanaugh JA, Potter JM, Abhayaratna WP, West NP, Glasgow N, Hawkins C, Armbruster D, Oakman C, Hickman PE.
    Pathology. 2015 Feb;47(2):138-44. doi: 10.1097/PAT.0000000000000227. Erratum in: Pathology. 2015 Jun;47(4):396. 
    PMID: 25551303
  18. Decision limits and the reporting of cardiac troponin: Meeting the needs of both the cardiologist and the ED physician.
    Hickman PE, Lindahl B, Cullen L, Koerbin G, Tate J, Potter JM.
    Crit Rev Clin Lab Sci. 2015 Feb;52(1):28-44. doi: 10.3109/10408363.2014.972497. Epub 2014 Nov 14.
    PMID: 25397345
  19. Free radical scavengers improve liver function but not morphological changes induced by reperfusion injury.
    Arab HA, Walker NI, Cheung K, Hickman PE, Potter JM, Kadkhodaee M, Roberts MS.
    J Invest Surg. 2015 Apr;28(2):77-85. doi: 10.3109/08941939.2014.971205. Epub 2014 Nov 13.
    PMID: 25393956
  20. Canadian Institutes of Health Research dissemination grant on high-sensitivity cardiac troponin.
    Kavsak PA, Jaffe AS, Hickman PE, Mills NL, Humphries KH, McRae A, Devereaux PJ, Lamy A, Whitlock R, Dhesy-Thind SK, Potter JM, Worster A.
    Clin Biochem. 2014 Nov;47(16-17):155-7. doi: 10.1016/j.clinbiochem.2014.10.002. Epub 2014 Oct 7. No abstract available. 
    PMID: 25304912
  21. Sensitivity of blood lipids to changes in adiposity, exercise, and diet in children.
    Telford RD, Cunningham RB, Waring P, Telford RM, Potter JM, Hickman PE, Abhayaratna WP.
    Med Sci Sports Exerc. 2015 May;47(5):974-82. doi: 10.1249/MSS.0000000000000493.
    PMID: 25202843
  22. Use of observed within-person variation of cardiac troponin in emergency department patients for determination of biological variation and percentage and absolute reference change values.
    Simpson AJ, Potter JM, Koerbin G, Oakman C, Cullen L, Wilkes GJ, Scanlan SL, Parsonage W, Hickman PE.
    Clin Chem. 2014 Jun;60(6):848-54. doi: 10.1373/clinchem.2013.219410. Epub 2014 Mar 4.
    PMID: 24594781
  23. Is it time to do away with the 99th percentile for cardiac troponin in the diagnosis of acute coronary syndrome and the assessment of cardiac risk?
    Hickman PE, Lindahl B, Potter JM, Venge P, Koerbin G, Eggers KM.
    Clin Chem. 2014 May;60(5):734-6. doi: 10.1373/clinchem.2013.217711. Epub 2014 Feb 21. No abstract available. 
Dr Marie Salib
Dr Marie Salib

Chemical pathology
MBBCH(Hons) MSC MD FRCPA MAACB

Roles:
Chemical Pathologist 
Staff Specialist, Chemical Pathology, ACT Pathology

Areas of Interest:
Endocrinology
Metabolic disorders
Gestational Diabetes Mellitus
Continuous development in Chemical Pathology
Medical Education

Contact Details:
Phone (02) 5124 8646
Fax (02) 5124 3398

Recent publications:

  1. Cross-sectional study of high-sensitivity cardiac troponins T and I in a hospital and community outpatient setting.
    Potter JM, Simpson AJ, Kerrigan J, Southcott E, Salib MM, Koerbin G, Hickman PE.
    Clin Biochem. 2017 Feb;50(3):105-109. doi: 10.1016/j.clinbiochem.2016.10.011. Epub 2016 Oct 22.
    PMID:  27780745
  2. Reassessment of lipaemic index threshold triggering high speed centrifugation of lipaemic specimens.
    Salib MM, Oakman C, Simpson AJ, Hickman PE, Potter JM.
    Pathology. 2017 Jun;49(4):423-424. doi: 10.1016/j.pathol.2016.12.352. Epub 2017 Apr 24. No abstract available.
    PMID: 28446363
  3. The relationship of plasma creatinine (as eGFR) and high-sensitivity cardiac troponin and NT-proBNP concentrations in a hospital and community outpatient population.
    Potter JM, Simpson AJ, Kerrigan J, Southcott E, Salib MM, Koerbin G, Hickman PE.
    Clin Biochem. 2017 Oct;50(15):813-815. doi: 10.1016/j.clinbiochem.2017.04.003. Epub 2017 Apr 6.
    PMID: 28392226
  4. Retrospective reassessment of gestational diabetes mellitus diagnosis by using the new classification.
    Salib MM, Hickman PE, Oakman C, Potter JM.
    Pathology. 2015 Jun;47(4):391-2. doi: 10.1097/PAT.0000000000000259. 
    PMID: 25938356
Professor Julia M Potter

Chemical Pathology
BMedSc(Hons 1)(UWA) MBBS(UWA) PhD(ANU) FRCPA FFSc(RCPA).

Roles:
Chemical Pathologist
Honorary Visiting Medical Officer. Chemical Pathology, ACT Pathology
Emeritus Professor, Australian National University Medical School

Areas of Interest:
Clinical Pharmacology
Clinical Chemistry

Contact Details:
Phone (02) 5124 2909
Fax (02) 5124 3398

Recent publications:

  1. Hickman PE, Lindahl B, Potter JM, Venge P, Koerbin GL, Eggers KM.  “Is it time to do away with the 99th percentile for troponin for the diagnosis of acute coronary syndrome and in the assessment of cardiac risk?” Clinical Chemistry. February 21, 2014 doi:10.1373/clinchem.2013.217711
  2. Telford RD, Cunningham RB, Waring P, Telford RM, Potter JM, Hickman PE, Abhayaratna WP. “Sensitivity of Blood Lipids to Changes in Adiposity, Exercise, and Diet in Children”. Med Sci Sports Exerc. 2014 Sep 8. [Epub ahead of print] PubMed PMID: 25202843.
  3. Hickman PE, Lindahl B, Cullen L, Koerbin G, Tate J, Potter JM. “Decision limits and the reporting of cardiac troponin: Meeting the needs of both the cardiologist and the ED physician”.  Crit Rev Clin Lab Sci, Early Online: 1–17. Nov 14. ISSN: 1040-8363 (print), 1549-781X (electronic) . DOI: 10.3109/10408363.2014.972497
  4. Kavsak PA, Jaffe AS, Hickman PE, Mills NL, Humphries KH, McRae A, Devereaux PJ, Lamy A, Whitlock R, Dhesy Thind SK, Potter JM, Worster A. Canadian Institutes of Health Research dissemination grant on high-sensitivity cardiac troponin. Clinical Biochemistry 2014; 47: 155-7.
  5. Arab HA, Walker NI, Cheung K, Hickman PE, Potter JM, Kakhodaee M, Roberts MS. “Free radical scavengers improve liver function but not morphological changes induced by reperfusion injury”. J Invest Surg. 2014; Nov 13. . [Epub ahead of print]
  6. Koerbin G, Cavanaugh JA, Potter JM, Abhayaratna WP, West NP, Glasgow N, Hawkins C, Armbruster D, Oakman C, Hickman PE. “Aussie Normals – An a priori Study to Develop Clinical Chemistry Reference Intervals in a Healthy Australian Population”. Pathology. ISSN 0031-3025/Online ISSN 1465-3931 DOI: 10.1097/PAT.0000000000000227 Jan 2015.
  7. Hickman PE, Lindahl B, Cullen L, Koerbin G, Tate J. Potter JM. “Decision limits and the reporting of cardiac troponin: Meeting the needs of both the cardiologist and the ED physician”. Crit Rev Clin Lab Sci, 2014. Early Online: 1–17. ISSN: 1040-8363 (print), 1549-781X (electronic) DOI: 10.3109/10408363.2014.972497
  8. Hickman PE, McGill D, Potter JM, Koerbin G, Apple FS, Talaulikar G. “Multiple Biomarkers Including Cardiac Troponins T and I Measured by High-sensitivity Assays, as Predictors of Long-term Mortality in Patients with Chronic Renal Failure Undergoing Dialysis”.  The American Journal of Cardiology (2015), doi: 10.1016/j.amjcard.2015.02.066. Am J Cardiol 2015; 115:1600-6
  9. Salib M, Hickman PE, Oakman C, Potter JM. Retrospective reassessment of Gestational Diabetes mellitus diagnoses by using the new classification. Pathology 2015; 47: 391-2. Doi: 10.1097/PAT.0000000000000259
  10. Chia NL, Slater HR, Potter JM. “Detection of segmental chromosome copy number gains by improved fluorescence in situ hybridization techniques”. J Assoc Genet Technol. 2015;41(1):5-11. PMID: 26030083
  11. Hughes D, Koerbin G, Potter JM, Glasgow N, West N, Abhayaratna WP, Cavanaugh J, Armbruster D, Hickman PE.  Harmonising reference intervals for three calculated parameters used in Clinical Chemistry. Clin Biochem Rev. 2016 Aug;37(3):105-111.
  12. Hickman PE, Koerbin G, Simpson AJ, Potter JM, H Hughes DG, Abhayaratna WP, West NP, Glasgow N, Armbruster D, Cavanaugh J, Reed M. “Using a thyroid disease-free population to define the reference interval for TSH and free T4 on the Abbott Architect analyser”.         Clin Endocrinology (Oxf). 2017 Jan;86(1):108-112. doi: 10.1111/cen.13143. Epub 2016 Jul 21.
  13. Potter JM, Simpson A, Kerrigan J, Southcott E, Salib MM, Koerbin G, Hickman PE. Cross-sectional study of high sensitivity cardiac troponins T and I in a hospital and community outpatient setting.  Clin Biochem. 2017 Feb;50(3):105-109. doi: 10.1016/j.clinbiochem.2016.10.011. Epub 2016 Oct 22.
  14. Hickman PE, Koerbin G, Potter JM, Abhayaratna WP. Statistical considerations for determining high-sensitivity cardiac troponin reference intervals. Clinical Biochemistry 2017; 50: 502–505. Mar 3. pii: S0009-9120(17)30076-0. doi: 10.1016/j.clinbiochem.2017.02.022. [Epub ahead of print] 
  15. Salib MM, Oakman C, Simpson A J, Hickman P E, Potter J M. “Reassessment of Lipaemic Index threshold triggering high speed centrifugation of lipaemic specimens”. Pathology. 2017 Jun;49(4):423-424. doi: 10.1016/j.pathol.2016.12.352. Epub 2017 Apr 24.
  16. Koerbin G, Potter JM, Andriolo K, West NP, Glasgow N, Hawkins C, Cavanaugh JA, Hickman PE. “Aussie Normals” – An a priori Study to Develop Reference Intervals in a Healthy Australian Population using the Beckman Coulter LH750™ Haematology Analyser as candidates for harmonised values.” Pathology 2017; 49: 518-525. [Epub ahead of print July 2017] https://doi.org/10.1016/j.pathol.2017.04.003 
  17. Potter JM, Simpson A, Kerrigan J, Southcott E, Salib MM, Koerbin G, Hickman PE. The relationship of plasma creatinine (as eGFR) and high-sensitivity cardiac troponin and NT- proBNP concentrations in a hospital and community outpatient population. Clinical Biochemistry. 2017 Oct; 50(15):813-815. doi: 10.1016/j.clinbiochem.2017.04.003. Epub 2017 Apr 6.
  18. Hickman PE, Koerbin G, Badrick T, Oakman C, Potter JM.  “The importance of low level QC for high sensitivity troponin assays.” Clinical Biochemistry. 2018 doi: 10.1016/ j.clinbiochem.2018.05.007
  19. Ehmann DMT, Hickman PE, Potter JM. “Are the changes in diagnostic criteria for Gestational Diabetes Mellitus reflected in pregnancy outcomes? A retrospective assessment.” Aust New Zealand J Obstetrics Gynaecology 2018 DOI: 10.1111/ajo.12956 2019: 1-6.

Abstracts of meeting presentations (some will also have publications)

  1. Chia NLN, Slater HR, Potter JM. “Confirmation of novel segmental copy number gain using improved fluorescence in situ hybridisation techniques”. RCPA Update, Melbourne, February 2014 
  2. Potter JM, Kesckes Z, Nouri-Girones F, Koerbin, G, Jayasinghe SB, Hickman PE. “Neonatal umbilical cord blood cardiac troponin as reflecting fetal growth, age and well-being”. AACC Chicago, July 2014.    
  3. Potter JM, Kesckes Z, Nouri-Girones F, Koerbin, G, SB Jayasinghe, Hickman PE. “Neonatal umbilical cord blood NT pro-BNP: does it reflect foetal growth, age and well-being?” AACB Adelaide, October 2014.
  4. Salib MM, Oakman C, Hickman PE, Potter JM.  “Retrospective reassessment of gestational diabetes mellitus diagnosis by using the new classification”. AACB Adelaide, October 2014.
  5. Newton S, Oakman C, Hickman PE, Hughes D, Badrick T, Salib  MM, Potter JM . “Glucose is a significant interferent with the Abbott Architect Jaffe Creatinine method”. AACB Adelaide, October 2014.
  6. Salib MM, Simpson AJ, Hickman PE, Apostoloska S, Yu C,  Potter JM.  “Flat Oral Glucose Tolerance Test Revisited”. AACB Sydney, September 2015.
  7. Hughes D,  Harris C, Burgess L, Vowles M, Estacio J,  Hickman PE, Simpson A, Potter JM. HbA1c across four platforms.  “The Abbott Architect enzymatic method, Bio-Rad Variant HPLC with the Alere Affinion and Roche b101 POC immunoassay methods”. AACB Sydney, September 2015
  8. Hughes D, Potter JM, Glasgow N , Cavanaugh J,, Koerbin G, Hickman PE. “Calculated Osmolality – A Reference Interval based on the Aussie Normal Study.” AACB Sydney, September 2015
  9. Hickman PE, Potter JM West N,  Armbruster D,  Cavanaugh J, Glasgow N,  Hughes D, Koerbin G. “Definitive  reference intervals for TSH on the Abbott Architect analyser”. AACB Sydney, September 2015
  10. Salib MM, Simpson AJ, Hickman PE, Apostoloska S, Yu C,  Potter J M. “Improving interpretation of flat oral Glucose Tolerance Tests in pregnancy.”  Update, RCPA Melbourne February 2016. 
  11. Koerbin G, Hughes D, Glasgow  N, Cavanaugh  J, Potter  JM, Hickman  PE, Yu  C, Simpson  AJ. Abbott “Architect Cortisol assay – time for a reference interval change?” AACB Brisbane, September 2016
  12. Salib MM, Oakman C, Simpson A J, Hickman P E, Potter J M. “Reassessment of Lipaemic Index threshold triggering high speed centrifugation of lipaemic specimens”. AACB Brisbane, September 2016
  13. Simpson AJ, Newton S, Ng A, Salib M, Oakman C, Yu C, Hickman PE, Potter JM. “Enzalutamide interference with digoxin measurement on Abbott Architect I-digoxin assay”. AACB Brisbane, September 2016
  14. Fam HL, Potter JM, Southcott EK, Shadbolt B, Nolan CJ. “Investigation of cardiac biomarkers in ambulatory Type 1 diabetic patients”. AACB Brisbane, September 2016
  15. Potter JM, Nouri-Girones F, Harris C, Southcott EK, Telford RM, Telford RD, Hickman PE. “Longitudinal changes in insulin resistance in childhood and adolescence; HOMA in the LOOK study”. AACB Brisbane, September 2016
  16. Potter JM, Salib MM, Simpson AJ, Oakman C, Hickman PE.  Is there seasonal variation in gestational diabetes? AACB Melbourne, September 2017.
  17. Ehmann DMT, Hickman PE, Potter JM. Are the changes in diagnostic criteria for Gestational Diabetes Mellitus reflected in pregnancy outcomes: a retrospective assessment? ADIPS Scientific Meeting, Canberra, October 2017
  18. Potter JM, Hickman PE, Simpson AJ, Oakman C, Woods C.  How pre-analytic handling changes a diagnosis and apparent incidence of disease: Gestational diabetes mellitus (GDM). AACB Sydney, September 2018.
  19. Potter JM, Southcott EK, Nouri-Girones F, Apostoloska S, Telford RD, Hickman PE.  Thyroid function in growing children; the Australian LOOK study. AACB Sydney, September 2018.
  20. Hickman PE, Koerbin G, Oakman C, Badrick T, Potter JM. The importance of low level QC for high sensitivity troponin assays. AACB Sydney, September 2018.
Dr Carolyn Hawkins
Dr Carolyn Hawkins

Director of Immunopathology
BSc MBBS MSc FRACP FRCPA

Roles:
Immunologist 
Senior Staff Specialist in Clinical Immunology and Allergy, Canberra Hospital Services
Lecturer, Australian National University Medical School

Areas of Interest:
All aspects of Immunopathology and in particular the assessment of autoimmunity and allergic disease

Contact Details:
Phone (02) 5124 3940
Fax (02) 5124 3398

Recent publications:

  1. Kuo JC, Hawkins CA, Yip D. Treatment outcomes of rapid desensitization protocols for chemotherapeutic agents and monoclonal antibodies. Int Med J  2014 44 (5) 442-9.
  2. Koerbin G, Cavanaugh JA, Potter JM Abhayaratna WP, West NP, Glasgow N, Hawkins C, Armbruster D, Oakman C, Hickman PE. ‘Aussie normals’: an a priori study to develop clinical chemistry reference intervals in a healthy Australian population. Pathology 2015;47:138-144.
  3. Sim BWC, Koo RM, Hawkins C, Bowden F, Watson A. Granulicatella adiacens subacute bacterial endocarditis as the underlying cause of type II mixed cryoglobulinaemia. BMJ Case Reports 2015; doi:10.1136
  4. Hsu, C-H, Hawkins C, Randall K. Retrospective audit of anaphylaxis management in the emergency department. Int Med J 2015:45 Suppl 4:1
  5. Paxton L, Hawkins C, Crispin, P. Selecting haematological malignancy patients for intravenous immunoglobulin. Int Med J 2016 46 (10):1216-18.
  6. Pucar PA, Hawkins CA, Randall KL, McNaughton E, Cook MC. Comparison of enzyme-linked immunosorbent assay and rapid chemiluminescent analyser in the detection of myeloperoxidase and proteinase 3 autoantibodies. Pathology 2017 49 (4):413-18.
  7. Randall KL, Hawkins CA. Antihistamines and allergy. Aust Prescr 2018;41:42-5 with accompanying Australian Prescriber Podcast.
Associate Professor Katrina Randall
Associate Professor Katrina Randall

Immunopathology
BSc(Hons) MBBS(Hons) PhD FRACP FRCPA

Roles: 
Immunologist 
Staff specialist, ACT Pathology
Associate Professor, Australian National University Medical School

Areas of Interest: 
Autoimmunity
Allergy
Primary Immunodeficiency

Contact Details:
Phone (02) 5124 8523
Fax (02) 5124 5543

Recent publications:

  1. Wilson AS, Law HD, Knobbe-Thomsen CB, Kearney CJ, Oliaro J, Binsfeld C, Burgio
    G, Starrs L, Brenner D, Randall KL, Brüstle A. Protection from EAE in DOCK8 mutant mice occurs despite increased Th17 cell frequencies in the periphery. Eur J Immunol. 2019 May;49(5):770-781. doi: 10.1002/eji.201847960. Epub 2019 Feb 20. 
    PubMed PMID: 30729501.
  2. Lee WI, Ford MC, Randall KL. IgE-mediated allergy to remifentanil? Anaesth Intensive Care. 2019 Jan;47(1):98-99. doi: 10.1177/0310057X18811730. Epub 2019 Feb 14.
    PubMed PMID: 30864483.
  3. Randall KL, Hawkins CA. Antihistamines and allergy. Aust Prescr. 2018 Apr;41(2):41-45. doi: 10.18773/austprescr.2018.013. Epub 2018 Apr 3. Review.
    PubMed PMID: 29670310; PubMed Central PMCID: PMC5895478.
  4. Penglase R, Garnham K, Daveson K, Randall KL. Symptomatic hypereosinophilia associated with Necator americanus self-inoculation. Intern Med J. 2018 Apr;48(4):475-477. doi: 10.1111/imj.13726.
    PubMed PMID: 29623983.
  5. Alshekaili J, Chand R, Lee CE, Corley S, Kwong K, Papa I, Fulcher DA, Randall KL, Leiding JW, Ma CS, Wilkins MR, Uzel G, Goodnow CC, Vinuesa CG, Tangye SG, Cook MC. STAT3 regulates cytotoxicity of human CD57+ CD4+ T cells in blood and lymphoid follicles. Sci Rep. 2018 Feb 23;8(1):3529. doi: 10.1038/s41598-018-21389-8.
    PubMed PMID: 29476109; PubMed Central PMCID: PMC5824848.
  6. Kearney CJ, Vervoort SJ, Ramsbottom KM, Freeman AJ, Michie J, Peake J, Casanova JL, Picard C, Tangye SG, Ma CS, Johnstone RW, Randall KL, Oliaro J. DOCK8 Drives Src-Dependent NK Cell Effector Function. J Immunol. 2017 Aug 9. pii: ji1700751. doi: 10.4049/jimmunol.1700751. [Epub ahead of print]
    PubMed PMID: 28794229.
  7. Pucar PA, Hawkins CA, Randall KL, Li C, McNaughton E, Cook MC. Comparison of enzyme-linked immunosorbent assay and rapid chemiluminescent analyser in the detection of myeloperoxidase and proteinase 3 autoantibodies. Pathology. 2017 Jun;49(4):413-418. doi: 10.1016/j.pathol.2017.02.006. Epub 2017 May 23.
    PubMed PMID: 28549721.
  8. Kearney CJ, Randall KL, Oliaro J. DOCK8 regulates signal transduction events to control immunity. Cell Mol Immunol. 2017 May;14(5):406-411. doi: 10.1038/cmi.2017.9. Epub 2017 Apr 3. Review.
    PubMed PMID: 28366940; PubMed Central PMCID: PMC5423093.
  9. Tangye SG, Pillay B, Randall KL, Avery DT, Phan TG, Gray P, Ziegler JB, Smart JM, Peake J, Arkwright PD, Hambleton S, Orange J, Goodnow CC, Uzel G, Casanova JL, Lugo Reyes SO, Freeman AF, Su HC, Ma CS. Dedicator of cytokinesis 8-deficient CD4(+) T cells are biased to a T(H)2 effector fate at the expense of T(H)1 and T(H)17 cells. J Allergy Clin Immunol. 2017 Mar;139(3):933-949. doi: 10.1016/j.jaci.2016.07.016. Epub 2016 Aug 20.
    PubMed PMID: 27554822.
  10. Janssen E, Tohme M, Hedayat M, Leick M, Kumari S, Ramesh N, Massaad MJ, Ullas S, Azcutia V, Goodnow CC, Randall KL, Qiao Q, Wu H, Al-Herz W, Cox D, Hartwig J, Irvine DJ, Luscinskas FW, Geha RS. A DOCK8-WIP-WASp complex links T cell receptors to the actin cytoskeleton. J Clin Invest. 2016 Oct 3;126(10):3837-3851. doi: 10.1172/JCI85774. Epub 2016 Sep 6.
    PubMed PMID: 27599296; PubMed Central PMCID: PMC5096816.
  11. Randall KL. Rituximab in autoimmune diseases. Aust Prescr. 2016 Aug;39(4):131-134. Epub 2016 Aug 1. Review.
    PubMed PMID: 27756976; PubMed Central PMCID: PMC4993704.
  12. Ange N, Rabbolini DJ, Pidcock M, Randall KL. 'Epinephrine-resistant' angioedema. BMJ Case Rep. 2016 Jan 28;2016. pii: bcr2015213880. doi: 10.1136/bcr-2015-213880.
    PubMed PMID: 26823364; PubMed Central PMCID: PMC4735189.
  13. Flesch IE, Randall KL, Hollett NA, Di Law H, Miosge LA, Sontani Y, Goodnow CC, Tscharke DC. Delayed control of herpes simplex virus infection and impaired CD4(+) T-cell migration to the skin in mouse models of DOCK8 deficiency. Immunol Cell Biol. 2015 Jul;93(6):517-21. doi: 10.1038/icb.2015.32. Epub 2015 Mar 17.
    PubMed PMID: 25776845; PubMed Central PMCID: PMC4496291.
  14. Sabouri Z, Schofield P, Horikawa K, Spierings E, Kipling D, Randall KL, Langley D, Roome B, Vazquez-Lombardi R, Rouet R, Hermes J, Chan TD, Brink R, Dunn-Walters DK, Christ D, Goodnow CC. Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity. Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2567-75. doi: 10.1073/pnas.1406974111. Epub 2014 May 12.
    PubMed PMID: 24821781; PubMed Central PMCID: PMC4078846.
Professor Matthew Cook
Professor Matthew Cook

Immunology
MBBS(Hons) PhD FRACP FRCPA FFSc (RCPA)

Roles:    
Immunologist
Professor of Medicine, Australian National University Medical School
Senior Staff Specialist and Director of Immunology, Canberra Hospital
Director, Canberra Clinical Genomics
Director, Centre for Personalised Immunology, Australian National University

Areas of Interest:
Immune deficiency and immune dysregulation (including autoimmunity)
Human genomics and precision medicine

Contact Details:
Phone (02) 5124 5586
Fax (02) 5124 5847

Recent publications:

  1. Cañete PF, Sweet RA, Gonzalez-Figueroa P, Papa I, Ohkura N, Bolton H, Roco JA, Cuenca M, Bassett KJ, Sayin I, Barry E, Lopez A, Canaday DH, Meyer-Herman M, Doglioni M, Fazekas de St. Groth B, Sakaguchi S, Cook MC  and Vinuesa CG. Regulatory roles of IL-10-producing human follicular T cells. J. Exp. Med. In press.
  2. Jiang SH, Athanasopoulos V, Ellyard J, Cappello J, Chuah A, Prabhu S, Papa I, Cardenas J, Gu J, Roco J, Yabas M, Walters GD, Burgio G, McKeon K, Enders A, Miosge L, Canete PF, Alexander S, Kitching AR, Fulcher D, Gatenby P, Babon J, Mallon D, Stone E, Wu P, Field MA, Andrews TD, Cho E, Pascual V, Cook MC and Vinuesa CG. Rare and low frequency variants in BLK and BANK1 impair IRF5 repression and predispose to systemic autoimmunity. Nature Commun. 2019. 10(1)2201.
  3. Cardinez C, Miraghazadeh B, Tanita K, Chand R, da Silva E, Hoshino A, Okada S, Chand R, Asano T, Tsumura M, Yoshida M, Ohnishi H, Kato Z, Yamazaki M, Okuno Y, Miyano S, Kojima S, Ogawa S, Andrews TD, Field M, BurgioG, Vinuesa CG, and Cook MC. Gain-of-function IKBKB mutation causes human combined immune deficiency. J Exp Med. 2018 Nov 5;215(11):2715-2724
  4. Alshekaili J, Chand R, Lee CE, Corley S, Papa I, Fulcher DA, Randall KL, Leiding JW, Ma CS, Wilkins MR,  Uzel G, Goodnow CC, Vinuesa CG, Tangye SG, Cook MC. STAT3 regulates cytotoxicity of human CD57+ CD4+ T cells in blood and lymphoid follicles. Sci Rep. 2018 Feb 23;8(1):3529. doi: 10.1038/s41598-018-21389-8.
  5. Miraghazadeh B and Cook MC. NF-kB in Autoimmunity. Front Immunol. 2018 Apr 9;9:613. doi: 10.3389/fimmu.2018.00613.
  6. Wu Z, Liang R, Ohnesorg T, Cho V, Lam W, Abhayaratna WP, Gatenby PA, Perera C, Zhang Y, Whittle B, Sinclair A, Goodnow CC, Field M, Andrews TD, Cook MC. Heterogeneity of human neutrophil CD177 expression results from CD177P1 pseudogene conversion. PLOS Genetics. 2016. 26;12(5):e1006067. doi: 10.1371/journal.pgen.1006067.
  7. Lee CE, Fulcher DA, Whittle B, Chand R, Fewings N, Field M, Andrews D, Goodnow CC, Cook MC.  Autosomal dominant B cell deficiency with alopecia due to a mutation in NFKB2 that results in non-processible p100. Blood 124(19):2964-72. 2014
Dr Gary Chew
Professor Matthew Cook

Immunology/Immunopathology
BSc MBBS PhD FRACP FRCPA

Role :
Staff Specialist, ACT Health

Areas of Interest: 
Autoimmunity
Allergy
Primary Immunodeficiency
Sarcoidosis

Contact Details:
Phone (02) 5124 8523
Fax (02) 5124 5543

Recent publications:

  1. Chew GYJ, Gatenby PA, Mercan S, De Malmanche T, Adelstein S, Garsia R, Hissaria P, French MA, Riminton DS, Fulcher DA, Scorza R,D'Alfonso S, Doria A, Rúa Figueroa I, Cervera R, Vasconcelos C, Martins B, Alarcón Riquelme M, Vinuesa CG and Cook MC. TNFRSF13B Variants in SLE and Immunodeficiency. J Clin Cell Immunol 2014; 5: 233. doi:10.4172/2155-9899.1000233.
  2. Chew GYJ, Sinha U, Wilson A, Gatenby P, DeMalmanche T, Adelstein S, Hissaria P, French M, Whittle B, Kirkpatrick P, Riminton DS, Fulcher DA, Cook MC. Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22). J Allergy Clin Immunol 2013 Apr;131(4):1130-5.
  3. Avery D, Deenick E, Ma S, Suryani S, Simpson N, Chew GY et al. B-cell intrinsic signalling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med 2010; 207: 155-71.
  4. Ma CS, Chew GYJ, Simpson N, Priyadarshi A, Wong M, Grimbacher B, Fulcher DA, Tangye SG, Cook MC. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT. J Exp Med 2008; 205(7): 1551-1557.
  5. Chew GYJ, Gatenby P. Inflammatory Myositis Complicating Hypocomplementaemic Urticarial Vasculitis Despite On-going Immunosuppression. Clin Rheumatol 2007; 26: 1370-1372.
  6. Cheung G, Chew G, Riminton S. Myeloperoxidase-antineutrophil cytoplasmic antibody seroconversion and fulminant vasculitis in Scl-70-positive scleroderma. Int Med J 2007; 37(3): 205-207.
Dr Michael Pidcock
Dr Michael Pidcock

Director of Haematology
MBBS FRACP FRCPA FRCP

Roles:
Clinical and Laboratory Haematologist 

Areas of Interest:
Management of all haematological malignancies
Autologous marrow transplantation
Cytogenetics and molecular genomics in haematological disorders
Immuno-phenotyping in haematological disorders
Diagnosis and management of haemophilia and other bleeding disorders
Medical education

Contact Details:
Phone (02) 5124 2894
Fax (02) 5124 2892

Associate Professor Dipti Talaulikar
Associate Professor Dipti Talaulikar

Haematology                           
PhD FRCPA FRACP SFHEA

Roles:
Clinical and laboratory haematologist
Senior Staff Specialist, Haematology, ACT Pathology
Associate Professor, Australian National University Medical School
Senior Fellow of the Higher education Academy
Examiner, Royal College of Pathologists of Australasia
Member of Steering Committee of the Lymphoma and related diseases Registry (LaRDR)
Member of the Medical and Scientific Advisory Group (MSAG), Myeloma Australia

Areas of Interest: 
Malignant haematology (lymphoma, leukaemia, myeloma, myeloproliferative neoplasms and myelodysplastic syndromes) 
Cytogenetics, molecular genetics and genomics
Medical education

Contact Details:
Phone (02) 5124 2487
Fax (02) 5124 2892

Recent publications:

  1. Wight JC, Yue M, Keane C, Johnston A, Linton K, Chin C, Wai SH, Talaulikar D, Gasiorowski R, Cheah CY, Gregory GP, Dickinson M, Minson A, Coombes C, Ku M, Lam S, Hawkes EA. Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance. Br J Haematol. 2019 Jun 24. 
  2. Keane C, Tobin J, Gunawardana J, Francis S, Gifford G, Gabrielli S, Gill A, Stevenson W, Talaulikar D, Gould C, Jain S, Birch S, Hertzberg M, Gandhi MK. The tumor microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV positive Diffuse Large B Cell Lymphoma. Eur J Haematol. 2019 Jun 18. 
  3. Castillo JJ, Itchaki G, Paludo J, Varettoni M, Buske C, Eyre TA, Chavez JC, Shain KH, Issa S, Palomba ML, Pasvolsky O, Simpson D, Talaulikar D, Tam CS, Tedeschi A, Ansell SM, Nayak L, Treon SP. Ibrutinib for the treatment of Bing-Neel syndrome: A multicenter study. Blood. 2018 Dec 6
  4. Mullen S, Talaulikar D. Acquired α-thalassemia associated with myelodysplastic syndromes. Blood. 2018 Nov 15;132(20):2209. 
  5. Cui Q, Vari F, Cristino AS, Salomon C, Rice GE, Sabdia MB, Guanzon D, Palma C, Mathew M, Talaulikar D, Jain S, Han E, Hertzberg MS, Gould C, Crooks P, Thillaiyampalam G, Keane C, Gandhi MK. Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma. Oncotarget. 2018 Oct 5;9(78):34644-34657. 
  6. Talaulikar D, Biscoe A, Lim JH, Gibson J, Arthur C, Mackinlay N, Saxena K, Cheng YY, Chen VM. Genetic analysis of Diffuse Large B-cell Lymphoma occurring in cases with antecedent Waldenström Macroglobulinaemia reveals different patterns of clonal evolution. Br J Haematol. 2018 Oct 18. 
  7. Keane C, Tobin J, Talaulikar D, Green M, Crooks P, Jain S, Gandhi M. A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival. Oncotarget. 2018 May 4;9(34):23620-23627. 
  8. Vari F, Arpon D, Keane C, Hertzberg MS, Talaulikar D, Jain S, Cui Q, Han E, Tobin J, Bird R, Cross D, Hernandez A, Gould C, Birch S, Gandhi MK. Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL. Blood. 2018 Apr 19;131(16):1809-1819. doi: 10.1182/blood-2017-07-796342.
  9. Lee OL, Horvath N, Lee C, Joshua D, Ho J, Szer J, Quach H, Spencer A, Harrison S, Mollee P, Roberts AW, Talaulikar D, Brown R, Augustson B, Ling S, Jaksic W, Gibson J, Kalff A, Johnston A, Kalro A, Ward C, Prince HM, Zannettino A. Bisphosphonate guidelines for treatment and prevention of myeloma bone disease. Intern Med J. 2017 Aug;47(8):938-951
  10. Ali El-Ayoubi1,2, James Q. Wang3, Nadine Hein3, Dipti Talaulikar1,2,3 Role of plasma cells in Waldenström Macroglobulinemia. Pathology journal, accepted for publication. 
  11. Dipti Talaulikar*, Constantine S. Tam*, Doug Joshua, Joy Ho, Jeff Szer, Hang Quach, Andrew Spencer, Simon Harrison, Peter Mollee, Andrew W. Roberts, Noemi Horvath, Cindy Lee, Andrew Zannettino, Ross Brown, Bradley Augustson, Wilfrid Jaksic, John Gibson, Anna Kalff, Anna Johnston, Judith Trotman Akash Kalro, George Grigoriadis, Chris Ward, and H. Miles Prince. Treatment of Patients with Waldenström Macroglobulinaemia: Clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Intern Med J. 2017 Jan;47(1):35-49. doi: 10.1111/imj.13311.
  12. Colm Keane, Clare Gould, Kimberley Jones, Dipti Talaulikar, David Hamm, Frank Vari, Erica Han, Peter Wood, Kim-Anh Le-Cao, Michael R. Green, Pauline Crooks, Sanjiv Jain, Josh Tobin, Raymond J. Steptoe, Maher K. Gandhi. The T cell Receptor repertoire is a key determinant of the tumour microenvironment and survival in Diffuse Large B cell Lymphoma. Clinical Cancer Research, in press. 
  13. Andrews TD, Jeelall Y, Talaulikar D, Goodnow CC, Field MA. “DeepSNVMiner: A sequence analysis tool to detect emergent, rare mutations in subsets of cell populations”.  PeerJ. 2016 May 24;4:e2074. doi: 10.7717/peerj.2074. eCollection 2016.
  14. Colm Keane, Frank Vari, Mark Hertzberg, Kim-Anh Le-Cao, Michael R. Green, Erica Han, John F. Seymour, Rodney J. Hicks, Devinder Gill, Pauline Crooks, Clare Gould, Kimberley Jones, Lyn R. Griffiths, Dipti Talaulikar, Sanjiv Jain, Josh Tobin, Maher K. Gandhi. Ratios of T-cell immune-effectors with tumour associated macrophages and PD-1/PD-L1 axis immune-checkpoint molecules, as prognosticators in diffuse large B cell lymphoma: a population-based study. Lancet Haematol. 2015 Oct;2(10):e445-55. doi: 10.1016/S2352-3026(15)00150-7. Epub 2015 Oct 1. 
  15. Sawang Petvises, Dipti Talaulikar, Helen C O’Neill. Human spleen contains a novel dendritic-like subset equivalent to mouse. Cell Mol Immunol. 2015 Apr 20. doi: 10.1038/cmi.2015.16
  16. Hang Quach, Doug Joshua, Joy Ho, Jeff Szer, Andrew Spencer, Simon Harrison, Peter Mollee, Andrew W. Roberts, Noemi Horvath, Dipti Talulikar, Bik To, Andrew Zannettino, Ross Brown, Laurence Catley, Bradley Augustson, Wilfrid Jaksic, John Gibson and H.Miles Prince.  Treatment of Patients with Multiple Myeloma who are Eligible for Stem Cell Transplantation: Position statement of the Myeloma Foundation Australia Medical and Scientific Advisory Group (MSAG). Intern Med J. 2015 Jan; 45(1):94-105.
  17. Hang Quach, Doug Joshua, Joy Ho, Jeff Szer, Andrew Spencer, Simon Harrison, Peter Mollee, Andrew W. Roberts, Noemi Horvath, Dipti Talulikar, Bik To, Andrew Zannettino, Ross Brown, Laurence Catley, Bradley Augustson, Wilfrid Jaksic, John Gibson and H.Miles Prince.  Treatment of Patients with Asymptomatic Multiple Myeloma and Symptomatic Multiple Myeloma who are Not Eligible for Stem Cell Transplantation: Position statement of the Myeloma Foundation Australia Medical and Scientific Advisory Group (MSAG). Intern Med J. 2015 Mar;45(3):335-43.
  18. N. Weber, P. Mollee , B. Augustson, R. Brown, L. Catley, J. Gibson, S. Harrison, P.J. Ho, N. Horvath, W. Jaksic, D. Joshua, H Quach, A.W. Roberts, A. Spencer, J. Szer, D. Talaulikar, B. To, A. Zannettino and H.M. Prince. Management of Systemic Light Chain (AL) Amyloidosis: Recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Intern Med J. 2015 Apr;45(4):371-82.
Dr Phillip Crispin
Dr Phillip Crispin

Haematology
BMBS(Hons) FRACP FRCPA

Roles:
Clinical and Laboratory Haematologist
Senior Staff Specialist, Haematology, ACT Pathology
Lecturer, Australian National University Medical School

Areas of Interest: 
Transfusion
Thrombosis and haemostasis
Patient blood management
General haematology

Contact Details:
Phone (02) 5124 3964
Fax (02) 5124 5544

Recent publications:

  1. Forwood KM, Lee E, Crispin PJ. Comparison of the bone marrow trephine sample quality between OnControl drill system and the Jamshedi needle.  Int J Lab Haematol. 2019; 41(3):373-79 DOI: 10.1111/ijlh.12984
  2. Crispin P, Koo RM. Genetic and molecular testing in thrombosis and haemostasis: Informing surveillance, treatment and prognosis. Semin Thromb Haemost. 2019 doi: 10.1055/s-0038-1677020.
  3. Crispin P, Stephens B, McArthur E, Sethna F. First trimester ferritin screening for pre-delivery anaemia as a patient blood management strategy. J Trans Apher Sci 2019 58(1):50-57
  4. Koo RM, Crispin P, Craft M, Lalloo S. Successful treatment of central nervous system myeloma manifesting as cauda equine nodules with intrathecal chemotherapy, lenalidomide and dexamethasone. BMJ Case Reports 2018. 10.1136/bcr-2018-226146
  5. Wong J, Wood E, Weinkove R, Crispin P, McQuilten ZK. Managing hypogammaglobulinaemia secondary to haematological malignancies in Australia and New Zealand: a clinician survey. Int. Med. J. 2019; 49(3):358-363. doi: 10.1111/imj.14082.
  6. Crispin P, Sethna F, Lim B. Iron in pregnancy (letter) Aust N Z J Obstet Gynaecol. 2018; 58(6) E29-30 DOI: 10.1111/ajo.12889
  7. Akers C, Savoia H, Kane S, Crispin P, Keegan A, Wood E, Glazebrook B, Bielby L, Davis AK. Misinterpretation of blood group antibody screen leading to serious errors in RhD immunoglobulin administration: a report on first two years of data from Serious Transfusion Incident Reporting program. Aust N Z J Obstet Gynaecol. 2019; 59(1): 161-164. DOI: 10.1111/ajo.12889
  8. Pratt J, Crispin P. Screening test for Direct Oral Anticoagulants with the Dilute Russell Viper Venom Time Eur J Haematol 2018; 100(6): 567-74 doi: 10.1111/ejh.13050. 
  9. Crispin P, Burgess M, Beath A. Unified infusion rates for 10% Intravenous immunoglobulin. Transfus Apher Sci 2018; 57: 243-6. doi: 10.1016/j.transci.2018.02.023. 
  10. Crispin P, Cheah PL. Autoimmune haemolytic anaemia and neuropathy with IgA osteosclerotic myeloma: A case report.  Pathology 2017 49(6): 646-7
  11. Crispin P, Holmes A. Clinical and Pathological Feature of Bone Marrow Granulomas: A modern Australian series International Journal of Laboratory Haematology 2018; 40(2): 123-7 doi: 10.1111/ijlh.12751 
  12. Unnikrishnan A, Papaemmanuil E, Beck D, Deshpande NP, Verma A, Kumari A, Woll PS, Richards LA, Knezevic K, Chandrakanthan V, Thoms JAI, Tursky ML, Huang Y, Ali Z, Olivier J, Galbraith S, Kulasekararaj AG, Magnus Tobiasson, Karimi M, Pellagatti A, Wilson SR, Lindeman R, Young B, Ramakrishna R, Arthur C, Stark R, Crispin P, Curnow J, Warburton P, Roncolato F, Boultwood J, Lynch K, Jacobsen STEW, Mufti GJ, Hellstrom-Lindberg E, Wilkins MR,  MacKenzie KL, Wong JWH, Campbell PJ and Pimanda JE.  Integrative genomics identifies the molecular basis of resistance to Azacitidine therapy in Myelodysplastic Syndromes. Cell Reports 2017 20(3): 572-585
  13. Stephens B, Sethna F, Crispin P. Postpartum obstetric red cell transfusion practice: A retrospective study in a tertiary obstetric centre. Aust NZ J Obstet Gynaecol 2018; 58(2): 170-7
  14. Flores CJ, Sethna F, Stephens B, Saxon B, Hong FS, Spigiel T, Burgess M, Connors B Crispin PJ.  Improving blood management in obstetrics: snapshots of a practice improvement partnership. BMJ Quality Improvement Reports 2017 23; 6(1):e000009. doi:10.1136/bmjquality-2017-000009 
  15. Paxton L, Crispin P, Hawkins C.  Selecting haematological malignancy patients for intravenous immunoglobulin Intern Med J. 2016; 46: 1216-18
  16. Crispin P, Sinclair F, Andriolo K.   Low haemoglobin density for detecting iron deficiency across a large population, including pregnancy Int J Lab Haematol. 2016; 38: 397-402. doi:10.1111/ijlh.12510
  17. Chen G, Crispin P, Cherian M, Dahlstrom J, Sethna FF, Kaye G, Pavli P, Subramanium K. Placental involvement by non-Hodgkin lymphoma in a Crohn disease patient on long term thiopurine therapy. Intern Med. J. 2016; 46(1): 102-5
  18. Eccles S, Crispin P, Vanniasinkam T. Risk Factors for Alloimmunisation in a Regional Tertiary Centre. Transfus Apher Sci 2015; 52(1): 60-4 
  19. Parakh S, Piggin A, Neeman T, Mitchell I, Crispin P, Davis A.  Outcomes of haematology  / oncology patients admitted to intensive care unit (ICU) at The Canberra Hospital (TCH). Intern Med J. 2014; 44(11) 1087-94Crispin P. Transfusion Reactions Hidden from History. Hoktoen International: A Journal of Medical Humanities 2014; 6(3) Summer
Dr Maya Latimer
Dr Maya Latimer

Acting director Clinical Haematology
MBBS FRACP FRCPA

Roles:
Clinical and laboratory haematologist
Coordinator of Advanced Training in haematology
Supervisor for the cytogenetics and molecular genomics lab
Chair of the lymphoma multidisciplinary meeting

Areas of Interest:
Lymphoma
Acute and chronic leukaemia
Myeloma
Bone marrow transplantation
Bone marrow failure syndromes
Medical education

Contact Details:
Phone (02) 5124 8514
Fax (02) 5124 5544

Dr James D'Rozario

Haematology
MBBS FRACP FRCPA

Roles:
Clinical and Laboratory Haematologist
Senior Staff Specialist, Haematology, ACT Pathology
Senior Lecturer, Australian National University Medical School

Areas of Interest:
Diagnosis and management of leukaemia and lymphoma
Immunophenotypic evaluation of leukaemia and lymphoproliferative disorders
Medical Education

Contact Details:
Phone (02) 5124 3965
Fax (02) 5124 2892

Recent publications:

  1. Spicka I, Ocio EM, Oakervee HE, Greil R. Banh R, Huang SY, D’Rozario J, Dimopoulos MA, Martinez S, Extrema S, Kahatt C, Alfaro V, Carella AM, Meuleman N, Hajek R, Symeonidis A, Min CK, Canell P, Ludwig H, Sonneveld P, Mateos MV. Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs dexametahasone alone in patients with relapsed/refractory multiple myeloma.  Ann Hematol 2019; https://doi.org/10.1007/s00277-019-0373-2 [E-pub ahead of print ]
  2. D’Rozario J, Bennett SK. Update on the role of venetoclax and rituximab in the treatment of relapsed and refractory CLL. Ther Adv Hematol 2019 ;10 (10): 1-12. 
  3. Hiwase D, Tan P, D’Rozario J, Taper J, Powell A, Irving I, Wright M, Brandford S, Yeung D, Anderson L, Gervasio O, Levetan C, Roberts W, Solterbeck A, Traficante R, Hughes T. Efficacy and safety of nilotinib 300mg twice daily in patients with chronic myeloid leukemia in chronic phase who are intolerant to prior tyrosine kinase inhibitors. Leuk Research 2018 (67): 109-115.
  4. Seymour JF, Kipps T , Eichhorst B, Hillmen P,  D’Rozario J, Assouline S, Owen C, Gerecitano J, Robak T, , De la Serna J,  Jaeger U, Cartron G,  Montillo M, Yan Li, Boyer M , Humphrey K, Mobasher M , Kater A.P. Venetoclax and rituximab in relapsed or refractory chronic lymphocytic leukemia. N Engl J Med. 2018; 378 (12): 1107- 1120
  5. Hein N, Hannan KM, D’Rozario J, Hannan RD . Inhibition of Pol 1 transcription: A new chance in the fight against cancer. Tech Cancer Research & Treatment. 2018; 
  6. Bradstock KF, Link E,  Di Iulio D, Lewis I.D, Schwarer A, Enno A, Marlton P, Szer J , Cull G, D’Rozario J,  Seymour JF Increased idarubicin dosage during consolidation therapy for adult acute myeloid leukemia improves leukemia-free survival. J Clin Oncol 2017; 35 (15) 1678- 1685.
  7. Hein N, Cameron D, Hannan KM, Nguyen, NN, Fong CY, Sornkorn J, Wall M,  Pavy M, Cullinane C, Diesch J, Devlin JR, George AJ, Sanji E, Quin J, Poortinga G, Verbrugge I, Baker A, Drygin D, Harrison SJ, D’Rozario J, Powell JA, Pitson SM, Zuber J, Johnstone RW, Dawson MA, Guthridge MA,  Wei A, McArthur GA, Pearson RB, Hannan RD.  Inhibition of Pol 1 transcription treats murine and human AML by targeting the leukemia initiating cell population. Blood 2017; 129(21)2882- 2895.
Dr Edwin Lee
Dr Maya Latimer

Haematology
MB ChB, MD, FRACP, FRCPA

Roles: 
Clinical and Laboratory Haematologist
Senior Staff Specialist, Haematology, ACT Pathology

Areas of Interest: 
Multiple myeloma
Amyloidosis

Contact Details:
Phone (02) 5124 8548
Fax (02) 5124 5544

Recent publications:

Comparison of the bone marrow trephine sample quality between OnControl drill system and the Jamshidi needle. International Journal of Laboratory Hematology, vol 41, p 373-9

Dr Nalini Pati

Haematology
MBBS MD DNB DCH (Syd) FRCPA FRACP

Roles: 
Clinical and Laboratory Haematologist
Senior Staff Specialist, Haematology, ACT Pathology
Clinical Senior Lecturer, Australian National University Medical School

Areas of Interest:
General Haematology including malignant haematology, bleeding disorder and paediatric haematology.

Contact Details:
Phone (02) 5124 8514
Fax (02) 5124 5544

Recent publications:

  1. Koo RM, Pati NK Haematological disorders in HIV, Text Book of management of HIV. (In Print) 
  2. George B, Pati NK, Kerridge I, Gottlieb D, Hertzberg M, Hoang G, Bradstock K. Pre-transplant cytomegalovirus sero status continues to remain the most important determinant of cytomegalovirus (CMV) reactivation following allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy. Transplant Infectious Disease Journal, 2010; 12: 322-329.
  3. Pati Nalini k, Sartor M,  Wong S, Nemet A, , Bradstock K F, Evaluation of the Role of Flow Cytometry as a Diagnostic Tool for Hereditary Spherocytosis Blood (ASH Annual Meeting Abstracts) 2008 112: Abstract 5381
  4. Pati Nalini K,  Garvin F, Antonenas V,  Kerridge I, Bradstock K F, Gottlieb D; Best Approach for Harvesting Bone Marrow to Maximize TNC and CD34+ Cell Counts Blood (ASH Annual Meeting Abstracts) 2008 112: Abstract 3468
  5. Favaloro E, Mohammed S, Pati Nalini, Ho MY, McDonald D; Doing more harm than good? A clinical audit of congenital thrombophilia investigation in tertiary practice. Pathology, 2011; 43 (3): 266-272.
  6. Crighton G, Haeusler G, Pati N, Connell T, Pneumocystis Jiroveci Pnemonia in an Infant with severe folate deficiency, The Paediatr Inf Dis J, 2011 (Aug); 30 (8): 
  7. Pati, NK, Yiu-Lam Kwan, Manoharan and Michael Theo. Induction with an Oral Chemotherapy- Cyclophosphamide in Combination with Idarubicin and Dexamethasone (CID) Followed By Early Autologous Stem Cell Transplantation for Multiple Myeloma Patients. Blood;(ASH Annual Meeting Abstracts) 2006 108: Abstract 5456
  8. C Gray, K Kalumba, N Pati, A Peterson, T Connell. Successful treatment of refractory immune thrombocytopenia with rituximab in a 10-week old infant. Accepted in the Journal of Paediatric Haematology Oncology.
  9. Barge L, Lwin Y, Pati N; Impact of a qualitative intervention with a unique febrile neutropenia management protocol in hematological patients in a tertiary centre. Hematology and Transfusion international Journal, 2017; 4 (4); 00090.
  10. Mishra S, Mishra P, Mishra S, Pati N; Acquired amegakaryocytic thrombocytopenia ina  child: a very rare case. Hematology and Transfusion international Journal, 2016; 2 (1); 00028.
  11. Barge L, Holmes AJ, Slade J, Pati N; Novel mutations resulting in a moderate to severe phenotypic manifestation of hemophilia A in a female; J of Pediatric Hematology / Oncology; 2017
  12. Grover SB, Pati NK, Saluja S, Bhowmik KT.  Solitary calvarial metastasis: An unusual presentation of thoracic neuroblastoma. Ind J Cancer,2003,  40 (3): 120-122
Dr Emma Palfreyman

Haematology
MBBS(Hons) FRACP FRCPA CCL(Ulm) 

Roles: 
Clinical and Laboratory Haematologist
Staff Specialist, Haematology, ACT Pathology

Areas of Interest: 
Bone marrow transplantation
Leukaemia
Lymphoma
Bone marrow failure syndromes 

Contact Details:
Phone (02) 5124 8548
Fax (02) 5124 5544

Dr Philip Choi
Dr Phil Choi

Haematology
BA BSc(Med) MBBS PhD FRACP FRCPA 

Roles: 
Clinical and Laboratory Haematologist

Areas of Interest:
Management of all haematological malignancies
Immune thrombocytopenia
Heparin induced thrombocytopenia
Disorders of platelet function

Contact details:
Phone (02) 5124 8514
Fax (02) 5124 5544

Recent publications:

  1. Benjamin Serpell, Stephen Freeman, David Ritchie, Philip Choi, Julien Periard, Avish Sharma. Altitude exposure as a training & iron overload management strategy post leukemia. Journal of Science and Medicine in Sport. In press, 2019
  2. Staples L, Milder T, Choi PY. Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone. Case Reports in Hematology, vol. 2017, Article ID 3476349, 2 pages, 2017. doi:10.1155/2017/3476349
  3. Choi PY, Roncolato F, Badoux X, Ramanathan S, Ho SJ, Chong BH. A novel triple therapy for ITP using high dose dexamethasone, low dose rituximab and cyclosporine (TT4). Blood. 2015;126(4):500-3.
  4. Iraqi M, Perdomo J, Yan F, Choi PY, Chong BH. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro. Haematologica. 2015;100(5):623-32.
  5. Chong BH, Choi PY, Khachigian L, Perdomo J. Drug-induced immune thrombocytopenia. Hematol Oncol Clin North Am. 2013;27(3):521-40.
  6. Choi PY, Gordon JE, Harvey M, Chong BH. Presentation and outcome of idiopathic thrombocytopenic purpura in a single Australian centre. Intern Med J. 2012;42(7):841-5.
  7. Choi PY, Rasko JEJ. The challenge of investigating thrombocytopenia. Medicine Today. 2011;12(2):26-35.
  8. Choi PY, Phillips KL, Rae I. High-dose intravenous flucloxacillin may affect warfarin therapy. Med J Aust. 2011;194(11):613.
  9. Choi PY, Dunkley S, Rasko JEJ. Immune thrombocytopenia: a diagnosis of exclusion. Medicine Today. 2011;12(3):41-6.
  10. Choi PY, Gibson J. Assessment of Haemostasis - Part 3. Medical Observer. 2010;August(27):23-5.
  11. Choi PY, Gibson J. Assessment of Haemostasis - Part 2. Medical Observer. 2010;August(20):27-9.
  12. Choi PY, Gibson J. Assessment of Haemostasis - Part 1. Medical Observer. 2010;August(13):23-5.
  13. Choi P. Perinephric Haematopoiesis. MJA 2008; 188 (4): 250
Dr Sam Bennett
Dr Sam Bennett

Haematology
MBBS FRACP FRCPA

Roles: 
Clinical and Laboratory Haematologist
Staff Specialist, Haematology, ACT Pathology

Associate Professor Karina Kennedy
Dr Karina Kennedy

Director of Clinical Microbiology
MBBS(Hons) MPH&TM Dip Trop Med & Hygiene FRCPA FRACP

Roles:
Deputy Executive Director, ACT Pathology
Director of Clinical Microbiology, ACT Pathology
Senior Staff Specialist, Infectious Diseases, Canberra Health Services
Clinical Associate Professor, Australian National University Medical School
ACT Representative, Public Health Laboratory Network 
ACT Representative, Communicable Diseases Genomics Network
Co-Chair, Australian and New Zealand Mycology Interest Group

Areas of Interest:
Diagnostic stewardship; Antimicrobial Resistance
Infection Control
Public Health Microbiology
Perinatal Infections
Infections in Immunocompromised Hosts

Contact Details:
Phone (02) 5124 2105
Fax (02) 5124 4646

Recent publications:

  1. Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study.
    Keighley C, Chen SC, Marriott D, Pope A, Chapman B, Kennedy K, Bak N, Underwood N, Wilson HL, McDonald K, Darvall J, Halliday C, Kidd S, Nguyen Q, Hajkowicz K, Sorrell TC, Van Hal S, Slavin MA.BMC Infect Dis. 2019;19(1):445.
  2. Talamantes-Becerra B, Carling J, Kennedy K, Gahan ME, Georges A. Identification of bacterial isolates from a public hospital in Australia using complexity-reduced genotyping. J Microbiol Methods. 2019;160:11-19.
  3. Andersson P, Beckingham W, Gorrie CL, Kennedy K, Daveson K, Ballard SA, Chen M, Roper K, Coatsworth N. Vancomycin-resistant Enterococcus (VRE) outbreak in a neonatal intensive care unit and special care nursery at a tertiary-care hospital in Australia-A retrospective case-control study. Infect Control Hosp Epidemiol. 2019;40(5):551-558.
  4. Sukumaran V, Cosh J, Thammavong A, Kennedy K, Ong CW. Vancomycin dependent Enterococcus: an unusual mutant? Pathology. 2019;51(3):318-320. 
  5. Biswas C, Marcelino VR, Van Hal S, Halliday C, Martinez E, Wang Q, Kidd S, Kennedy K, Marriott D, Morrissey CO, Arthur I, Weeks K, Slavin MA, Sorrell TC, Sintchenko V, Meyer W, Chen SC. Whole Genome Sequencing of Australian Candida glabrata Isolates Reveals Genetic Diversity and Novel Sequence Types. Front Microbiol. 2018;3(9):2946. 
  6. Kengen R, Thoonen E, Daveson K, Loong B, Rodgers H, Beckingham W, Kennedy K, Suwandarathne R, van Haren F.  Chlorhexidine washing in intensive care does not reduce bloodstream infections, blood culture contamination and drug-resistant microorganism acquisition: an interrupted time series analysis. Crit Care Resusc. 2018;20(3):231-240.
  7. Vangchhia B, Blyton MDJ, Collignon P, Kennedy K, Gordon DM. Factors affecting the presence, genetic diversity and antimicrobial sensitivity of Escherichia coli in poultry meat samples collected from Canberra, Australia. Environ Microbiol. 2018;20(4):1350-1361. 
  8. Wilson HL, Kennedy KJ, Moffatt CRM. Epidemiology of non-typhoid Salmonella infection in the Australian Capital Territory over a 10-year period. Intern Med J. 2018;48(3):316-323. 
  9. Biswas C, Chen SC, Halliday C, Martinez E, Rockett RJ, Wang Q, Timms VJ, Dhakal R, Sadsad R, Kennedy KJ, Playford G, Marriott DJ, Slavin MA, Sorrell TC, Sintchenko V. Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance..J Vis Exp. 2017;28(130). doi: 10.3791/56714.
  10. Gordon DM, Geyik S, Clermont O, O'Brien CL, Huang S, Abayasekara C, Rajesh A, Kennedy K, Collignon P, Pavli P, Rodriguez C, Johnston BD, Johnson JR, Decousser JW, Denamur E. Fine-Scale Structure Analysis Shows Epidemic Patterns of Clonal Complex 95, a Cosmopolitan Escherichia coli Lineage Responsible for Extraintestinal Infection. mSphere. 2017;2(3):pii: e00168-17.
  11. Biswas C, Chen SC, Halliday C, Kennedy K, Playford EG, Marriott DJ, Slavin MA, Sorrell TC, Sintchenko V. Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study. Clin Microbiol Infect. 2017;23(9):676.e7-676.e10.
  12. Moffatt CRM, Moloi SB, Kennedy KJ. First case report of myopercarditis linked to Campylobacter coli enterocolitis.  BMC Infect Dis. 2017;17:1.  
  13. Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, Bak N, Heath C, Kennedy K, et al. Changing epidemiology of candidaemia in Australia. J Antimicrob Chemother.  2017;72(4):1103-1108.  
  14. Das A, Kennedy K, Spyropoulos G, Collignon P. Administrative data has poor accuracy for surveillance of Staphylococcus aureus bacteraemia. Infect Dis Health.  2016;21:162-8
  15. Halliday CL, Chen SC, Kidd SE, van Hal S, Chapman B, Heath CH, Lee A, Kennedy KJ, Daveson K, Sorrell TC, Morrissey CO, Marriott DJ, Slavin MA. Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations. Int J Antimicrob Agents. 2016;48:453-8. 
  16. Vangchhia B, Abraham S, Bell JM, Collignon P, Gibson JS, Ingram PR, Johnson JR, Kennedy K, Trott DJ, Turnidge JD, Gordon DM.  Phylogenetic Diversity, Antimicrobial Susceptibility and Virulence Characteristics of Phylogroup F Escherichia coli in Australia.  Microbiology. 2016; 162:1904-1912. 
  17. Kennedy KJ, Daveson K, Slavin MA, van Hal SJ, Sorrell TC, Lee A, Marriott DJ, Chapman B, Halliday CL, Hajkowicz K, Athan E, Bak N, Cheong E, Heath CH, Morrissey CO, Kidd S, Beresford R, Blyth C, Korman TM, Robinson JO, Meyer W, Chen SC; Australia and New Zealand Mycoses Interest Group. Mucormycosis in Australia: contemporary epidemiology and outcomes. Clin Microbiol Infect. 2016; 22:775-781.  
  18. Ballard MS, Schønheyder HC, Knudsen JD, Lyytikäinen O, Dryden M, Kennedy KJ, Valiquette L, Pinholt M, Jacobsson G, Laupland KB; International Bacteremia Surveillance Collaborative. The changing epidemiology of group B streptococcus bloodstream infection: A multinational population-based assessment. Infect Dis. 2016; 48:386-91.  
  19. Collignon P, Kennedy KJ. Long-term persistence of multidrug-resistant Enterobacteriaceae after travel (letter). Clin Infect Dis. 2015;61:1766-7.  
  20. Wailan AM, Paterson DL, Kennedy K, Ingram PR, Bursle E, Sidjabat HE. Genomic characteristics of NDM-producing Enterobacteriaceae isolates in Australia and their blaNDM genetic contexts.  J Antimicrob Agents Chemother. 2015;60:136-41.  
  21. Slavin M, van Hal S, Sorrell TC, Lee A, Marriott DJ, Daveson K, Kennedy K, Hajkowicz K, Halliday C, Athan E, Bak N, Cheong E, Heath CH, Orla Morrissey C, Kidd S, Beresford R, Blyth C, Korman TM, Owen Robinson J, Meyer W, Chen SC; Australia and New Zealand Mycoses Interest Group. Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality.  Clin Microbiol Infect. 2015;21:490. e1-490. e10.  
  22. Marginson M, Daveson KL, Kennedy KJ. Clinical impact of reducing routine blood culture incubation time from seven to five days. Pathology. 2014;46:636-9.  
  23. Ingram PR, Cheng AC, Murray R.J, Blyth C, Walls T, Fisher DS, Davis JS, Kennedy K, Abbott I, Kanapathipillai R, Madigan V.  What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore. Clin Microbiol Infect. 2014; 20:O737-44. 
  24. Appuhamy R, Moffatt C, Davis S, Kelly P, Kennedy K.  Hepatitis E in a food handler – a rapid risk assessment to guide the public health response. Western Pac Surveill Response J 2014;5:1.  
  25. Moffatt C, Appuhamy R, Andrew W, Wynn S, Roberts J, Kennedy K. An assessment of risk posed by a Campylobacter-positive puppy living in an Australian residential aged care facility.  Western Pac Surveill Response J. 2014;5.  
  26. Blyton MD, Cornall SJ, Kennedy K, Collignon P, Gordon DM. Sex-dependent competitive dominance of phylogenetic group B2 Escherichia coli strains within human hosts. Environ Micro Reports. 2014; 6:605-610.  
  27. Slimings C, Armstrong P, Beckingham WD, Bull AL, Hall L, Kennedy KJ, et al. Increasing incidence of Clostridium difficile infection, Australia, 2011-2012. MJA 2014; 200:272-276.  
  28. Tom S, Galbraith JC, Valiquette L, Jacobsson G, Collignon P, Schonheyder HC, Sogaard M, Kennedy KJ, Knudsen JD, Ostergaard C, Lyytikainen O, Laupland KB. Case fatality ratio and mortality rate trends of community-onset Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2014;20:O630-2.  
Professor Peter Collignon AM
Professor Peter Collignon

Clinical Microbiology and Infectious Diseases
MBBS(Hons) BSc(Med) PhD FRACP FRCPA FASM

Roles:                 
Senior Staff Specialist, Clinical Microbiology, ACT Pathology
Professor, Australian National University Medical School

Areas of Interest: 
Antibiotic resistance and the development of resistance through the use of antibiotics - both in food animals and people
Healthcare associated infections, infection prevention and control in hospitals and healthcare facilities
Spread of infections and antibiotic resistant bacteria thru water as well as Teaching and Research

National Awards:
Member of the Order of Australia (AM) June 2010 
Appointed as a Member for service to medicine, particularly as a practitioner and educator in the fields of clinical microbiology, infectious diseases and infection control.

Contact Details: 
Phone (02) 6244 2105
Fax (02) 5124 4646

Recent publications:

  1. Collignon P, Beggs JJ. Socioeconomic Enablers for Contagion: Factors Impelling the Antimicrobial Resistance Epidemic. Antibiotics (Basel). 2019 Jun 30;8(3). 
  2. Mitchell BG, Fasugba O, Cheng AC, Gregory V et al. .Chlorhexidine versus saline in reducing the risk of catheter associated urinary tract infection: A cost-effectiveness analysis. Int J Nurs Stud. 2019 Apr 13;97:1-6. 
  3. Limmathurotsakul D, Sandoe JAT, Barrett DC, Corley M et al. 'Antibiotic footprint' as a communication tool to aid reduction of antibiotic consumption. J Antimicrob Chemother. 2019 May 10. 
  4. Fasugba O, Cheng AC, Gregory V, Graves N et al. Chlorhexidine for meatal cleaning in reducing catheter-associated urinary tract infections: a multicentre stepped-wedge randomised controlled trial. Lancet Infect Dis. 2019 Jun;19(6):611-619. 
  5. Hendriksen RS, Munk P, Njage P, van Bunnik B et al. Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage. Nat Commun. 2019 Mar 8;10(1):1124. 
  6. Collignon P, Beggs JJ, Walsh TR, Gandra S, Laxminarayan R. Antibiotic resistance, stewardship, and consumption - Authors' reply. Lancet Planet Health. 2019 Feb;3(2):e68. 
  7. Collignon PJ, McEwen SA. One Health-Its Importance in Helping to Better Control Antimicrobial Resistance. Trop Med Infect Dis. 2019 Jan 29;4(1). pii:E22. 
  8. Fasugba O, Das A, Mnatzaganian G, Mitchell BG, Collignon P, Gardner A. Incidence of single-drug resistant, multidrug-resistant and extensively drug-resistant Escherichia coli urinary tract infections: An Australian laboratory-based retrospective study. J Glob Antimicrob Resist. 2019 Mar;16:254-259. 
  9. Collignon P, Beggs JJ, Walsh TR, Gandra S, Laxminarayan R. Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis. Lancet Planet Health. 2018 Sep;2(9):e398-e405. 
  10. McEwen SA, Angulo FJ, Collignon PJ, Conly JM. Unintended consequences associated with national-level restrictions on antimicrobial use in food-producing animals. Lancet Planet Health. 2018 Jul;2(7):e279-e282. 
  11. Garland SM, Dimech W, Collignon P; Australian Clinical Microbiologists Infectious Diseases Group. The new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining quality. J Pathol Clin Res.2018 Oct;4(4):207-212. 
  12. McEwen SA, Collignon PJ. Antimicrobial Resistance: a One Health Perspective. Microbiol Spectr. 2018 Mar;6(2). 
  13. Aidara-Kane A, Angulo FJ, Conly JM, Minato Y, Silbergeld EK, McEwen SA, Collignon PJ; WHO Guideline Development Group. World Health Organization (WHO) guidelines on use of medically important antimicrobials in food-producing animals. Antimicrob Resist Infect Control. 2018 Jan 17;7:7.
  14. Vangchhia B, Blyton MDJ, Collignon P, Kennedy K, Gordon DM. Factors affecting the presence, genetic diversity and antimicrobial sensitivity of Escherichia coli in poultry meat samples collected from Canberra, Australia. Environ Microbiol.2018 Apr;20(4):1350-1361. 
  15. Mitchell BG, Fasugba O, Gardner A, Koerner J, Collignon P, Cheng AC, Graves N, Morey P, Gregory V. Reducing catheter-associated urinary tract infections in hospitals: study protocol for a multi-site randomised controlled study. BMJ Open.2017 Nov 28;7(11):e018871. 
  16. Pulcini C, Collignon P. Hospital antimicrobial stewardship: the way forward. Lancet Infect Dis. 2017 Nov;17(11):1120. 
  17. Del Mar C, Collignon P. How can we prepare better for influenza epidemics? BMJ. 2017 Nov 2;359:j5007. 
  18. Shaban RZ, Maloney S, Gerrard J, Collignon P et al. Outbreak of health care-associated Burkholderia cenocepacia bacteremia and infection attributed to contaminated sterile gel used for central line insertion under ultrasound guidance and other procedures. Am J Infect Control. 2017 Sep 1;45(9):954-958. 
  19. Gordon DM, Geyik S, Clermont O, O'Brien CL et al.  Fine-Scale Structure Analysis Shows Epidemic Patterns of Clonal Complex 95, a Cosmopolitan Escherichia coli Lineage Responsible for Extraintestinal Infection. mSphere. 2017 May 31;2(3). pii: e00168-17. 
  20. Collignon PJ, Conly JM, Andremont A, McEwen SA, Aidara-Kane A. Reply to Cohen and Denning. Clin Infect Dis. 2017 Apr 1;64(7):987-988. 
  21. De Serres G, Skowronski DM, Ward BJ, Gardam M et al. Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement. PLoS One. 2017 Jan 27;12(1):e0163586.
  22. Collignon PJ, Lum GD, Robson JM. Does Lyme disease exist in Australia? Med J Aust. 2016 Nov 7;205(9):413-417. PubMed PMID: 27809728.
  23. Fasugba O, Mitchell BG, Mnatzaganian G, Das A, Collignon P, Gardner A. Five-Year Antimicrobial Resistance Patterns of Urinary Escherichia coli at an Australian Tertiary Hospital: Time Series Analyses of Prevalence Data. PLoS One. 2016 Oct 6;11(10):e0164306. 
  24. Vangchhia B, Abraham S, Bell JM, Collignon P, Gibson JS, Ingram PR, Johnson JR, Kennedy K, Trott DJ, Turnidge JD, Gordon DM. Phylogenetic diversity, antimicrobial susceptibility and virulence characteristics of phylogroup F Escherichia coli in Australia. Microbiology. 2016 Nov;162(11):1904-1912. 
  25. Coombs GW, Daley DA, Thin Lee Y, Pearson JC, Robinson JO, Nimmo GR, Collignon P, Howden BP, Bell JM, Turnidge JD; Australian Group on Antimicrobial Resistance .Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2014. Commun Dis Intell Q Rep. 2016 Jun 30;40(2):E244-54. 
  26. Collignon PJ, Conly JM, Andremont A, McEwen SA, Aidara-Kane A; World Health Organization Advisory Group, World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal Production. Clin Infect Dis. 2016 Oct 15;63(8):1087-1093. 
  27. Ballard MS, Schønheyder HC, Knudsen JD, Lyytikäinen O et al. International Bacteremia Surveillance Collaborative. The changing epidemiology of group B streptococcus bloodstream infection: a multi-national population-based assessment. Infect Dis (Lond). 2016;48(5):386-91. 
  28. Lahra MM; Australian Gonococcal Surveillance Programme. Australian Gonococcal Surveillance Programme annual report, 2014. Commun Dis Intell Q Rep. 2015 Sep 30;39(3):E347-54. 
  29. Collignon P. Antibiotic resistance: are we all doomed? Intern Med J. 2015 Nov;45(11):1109-15. 
  30. Collignon P, Kennedy KJ. Long-term persistence of multidrug-resistant Enterobacteriaceae after travel. Clin Infect Dis. 2015 Dec 1;61(11):1766-7. 
  31. Tartari E, Allegranzi B, Ang B, Calleja N, Collignon P, et al.; Preparedness of institutions around the world for managing patients with Ebola virus disease: an infection control readiness checklist. Antimicrob Resist Infect Control. 2015 Jun 8;4:22. 
  32. Collignon P, Voss A. China, what antibiotics and what volumes are used in food production animals? Antimicrob Resist Infect Control. 2015 Apr 23;4:16.
  33. Collignon P, Athukorala PC, Senanayake S, Khan F. Antimicrobial resistance: the major contribution of poor governance and corruption to this growing problem. PLoS One. 2015 Mar 18;10(3):e0116746. 
  34. Turnidge JD, Gottlieb T, Mitchell DH, Coombs GW, et al: Australian Group on Antimicrobial Resistance. Enterobacteriaceae Sepsis Outcome Programme annual report, 2013. Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E327-33
  35. Coombs GW, Pearson JC, Daly DA, Le TT et al.; Australian Group on Antimicrobial Resistance. Australian Enterococcal Sepsis Outcome Programme annual report, 2013. Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E320-6. 
  36. Coombs GW, Nimmo GR, Daly DA, Le TT et al.: Australian Group on Antimicrobial Resistance. Australian Staphylococcus aureus Sepsis Outcome Programme annualreport, 2013. Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E309-19.
  37. Coombs GW, Daly DA, Pearson JC, Nimmo GR et al.; Australian Group on Antimicrobial Resistance. Community-onset Staphylococcus aureus Surveillance Programme annual report, 2012. Commun Dis Intell Q Rep. 2014 Mar 31;38(1):
  38. Turnidge JD, Gottlieb T, Mitchell DH, Coombs GW et al.; Australian Group on Antimicrobial Resistance. Community-onset Gram-negative Surveillance Program annual report, 2012. Commun Dis Intell Q Rep. 2014 Mar 31;38(1).
  39. Turnidge JD, Gottlieb T, Mitchell DH, Coombs GW et al.; Australian Group on Antimicrobial Resistance. Hospital-onset Gram-negative Surveillance Program annual report, 2011. Commun Dis Intell Q Rep. 2014 Mar 31;38(1):E49-53. 
  40. Collignon P, Doshi P, Del Mar C, Jefferson T. Safety and efficacy of inactivated influenza vaccines in children. Clin Infect Dis. 2015 Feb 1;60(3):489. 
  41. Graham DW, Collignon P, Davies J, Larsson DG, Snape J. Underappreciated role of regionally poor water quality on globally increasing antibiotic resistance. Environ Sci Technol. 2014 Oct 21;48(20):11746-7. 
  42. Mitchell BG, Collignon PJ, McCann R, Wilkinson IJ, Wells A. Reply to Worth et al. Clin Infect Dis. 2014 Dec 15;59(12):1809-10. 
  43. Collignon PJ. Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older. Med J Aust. 2014 Aug 18;201(4):199-200. 
  44. Mitchell BG, Collignon PJ, McCann R, Wilkinson IJ, Wells A. A major reduction in hospital-onset Staphylococcus aureus bacteremia in Australia-12 years of progress: an observational study. Clin Infect Dis. 2014 Oct;59(7):969-75. 
  45. Tom S, Galbraith JC, Valiquette L, Jacobsson G, Collignon P et al.; International Bacteraemia Surveillance Collaborative. Case fatality ratio and mortality rate trends of community-onset Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2014 Oct;20(10):O630-2
  46. Coombs GW, Pearson JC, Daley DA, Le T et al.;  Australian Group on Antimicrobial Resistance. Molecular epidemiology of enterococcal bacteremia in Australia. J Clin Microbiol. 2014 Mar;52(3):897-905. 
Dr Chong Wei Ong
Dr Chong Wei Ong

Clinical Microbiology
MBBS(Hons) FRACP FRCPA

Roles:
Staff Specialist, Clinical Microbiology, ACT Pathology
Specialty Lead, Infectious Immunoassay, ACT Pathology
Staff Specialist, Infectious Diseases, Canberra Health Services (Calvary Public Hospital Bruce)
Infection Control Physician, Calvary Public Hospital Bruce

Areas of Interest:
Serological diagnosis of infectious diseases
Perinatal Infections
Infection Control

Contact details
Phone (02) 5124 2105
Fax (02) 5124 4646

Recent publications:

  1. Sukumaran V, Cosh J, Thammavong A, Kennedy K, Ong CW. Vancomycin dependent Enterococcus: an unusual mutant? Pathology. 2019 Apr;51(3):318-320.
  2. Sherley M, Ong CW. Sexual transmission of Zika virus: a literature review. Sex Health. 2018 Jun;15(3):183-199. doi: 10.1071/SH17046.
  3. Wilson HL, Ong CW. Bifidobacterium longum vertebrodiscitis in a patient with cirrhosis and prostate cancer. Anaerobe. 2017 Oct;47:47-50.
  4. Ong CW. Zika virus: an emerging infectious threat. Intern Med J. 2016 May;46(5):525-30. 
  5. Daveson KL, Ong CW, Bowden S, Koina ME, Hallam LA. BK virus-associated progressive multifocal leukoencephalopathy. Med J Aust. 2013 Mar 4;198(4):216-8.
  6. Ong CW, Roberts JL, Collignon PJ. Long-term survival outcome following Staphylococcus
  7. aureus bacteraemia. Healthcare Infection. 2013; 18(3):102-109. 
  8. Ong CW. Norovirus: a challenging pathogen. Healthcare Infection. 2013;18(4):133-142. 
  9. Australian Commission on Safety and Quality in Health Care. Recommendations for the control
  10. of Multi-drug resistant Gram-negatives: carbapenem resistant Enterobacteriaceae (October 2013). Sydney. ACSQHC, 2013.
  11. Jackson J, McGregor A, Cooley L, Ng J, Brown M, Ong CW, Darcy C, Sintchenko V. Francisella tularensis subspecies holarctica, Tasmania, Australia, 2011. Emerg Infect Dis. 2012 Sep;18(9):1484-6.
  12. Ong C, Barnes S, Senanayake S. Actinomyces turicensis infection mimicking ovarian tumour.
  13. Singapore Med J. 2012 Jan;53(1):e9-e11.
  14. Cheah PL, Ong CW, Crispin P. Microbial contamination of autologous peripheral blood stem cell products: incidence, clinical outcome, quality control and management strategies. Pathology. 2011 Jun;43(4):340-5.
  15. Ong C, Ahmad O, Senanayake S, Buirski G, Lueck C. Optic neuritis associated with Q fever:
  16. case report and literature review. Int J Infect Dis. 2010 Sep;14 Suppl 3:e269-73. 
  17. Kennedy KJ, Jadeer AA, Ong CW, Senanayake SN, Collignon PJ. Two cases of Streptococcus suis endocarditis in Australian piggery workers. Med J Aust. 2008 Oct 6;189(7):413.
Dr Heather Wilson
Dr Heather Wilson

Clinical Microbiology
BSc (Hons) MBBS PhD FRACP FRCPA

Roles:
Staff Specialist, Clinical Microbiology, ACT Pathology
Specialty Lead, Molecular Microbiology, ACT Pathology
Staff Specialist, Infectious Diseases, Canberra Health Services
Adverse Drug Reaction Reporting Committee Member, Canberra Health Services

Areas of Interest:
Molecular microbiology
Infections in the immunocompromised host
Mycology
Antimicrobial susceptibility and resistance

Contact Details:
Phone (02) 5124 2105
Fax (02) 6244 4646

Recent publications:

  1. Keighley C, Chen SC-A, Marriott D, Pope A, Chapman B, Kennedy K, Bak N, Underwood N, Wilson HL, McDonald K, Darvall J, Halliday C, Kidd S, Nguyen Q, Hajkowicz K, Sorrell TC, Van Hal S, Slavin MA. Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study. BMC Infectious Diseases (2019), 19: 445.
  2. Wilson HL, Daveson K, Del Mar CB. Optimal antimicrobial duration for common bacterial infections. Australian Prescriber (2019), 42: 5.
  3. Shaban RZ, Maloney S, Gerrard J, Collignon P, Macbeth D, Cruickshank M, Hume A, Jennison A, Bergh H, Wilson HL, Derrington P. Outbreak of healthcare-associated Burkholderia cenocepacia bacteraemia and infection attributed to contaminated ‘sterile’ gel used for central line insertion under ultrasound guidance and other procedures. American Journal of Infection Control (2017), 45:954.
  4. Smibert OC, Wilson HL, Sohail A, Narayanasamy S, Schultz MB, Ballard SA, Kwong JC, de Boer J, Morrissey O, Peleg AY, Snell G, Paraskeva M, Jenney AWJ. Donor-derived Mycoplasma hominis and a cluster of M. hominis cases in solid organ transplant recipients. Clinical Infectious Diseases (2017), 65:1504.
  5. Wilson HL, Moffatt CM, Kennedy KJ. Epidemiology of non-typhoid Salmonella infection in the Australian Capital Territory over a 10 year period. Internal Medicine Journal (2017), 48:316.
  6. Wilson HL, Tran T, Druce J, Dupont-Rouzeyrol M, Catton M.  A neutralization assay for Zika and Dengue viruses using a real-time PCR-based endpoint assessment. Journal of Clinical Microbiology (2017), 55:3104.
  7. Kong KL, Lau J, Goh SM, Wilson HL, Catton M, Korman TM. Myocarditis caused by human parechovirus in man. Emerging Infectious Diseases (2017), 23:1578.
  8. Wilson HL, Ong C. Bifidobacterium longum vertebrodiscitis in a patient with cirrhosis and prostate cancer. Anaerobe (2017), 47: 47.
Dr Anindita Das
Dr Anindita Das

Clinical Microbiology
MBBS MD DNB FRCPA

Roles: 
Staff Specialist, Clinical Microbiology, ACT Pathology
Medical Microbiology Specialist, Australian Red Cross Blood Service

Areas of Interest: 
Antimicrobial Resistance
Hospital infection control
Public health and infectious diseases
Transfusion transmitted infections

Contact Details:
Phone (02) 5124 2922
Fax (02) 6244 4646

Recent publications:

  1. Fasugba O, Mitchell B, Mnatzaganian G, Das A, Collignon P, Gardner A. Five-year Antimicrobial Resistance Patterns of Urinary Escherichia coli at an Australian Tertiary Hospital: Time Series Analysis of Prevalence Data. PLOS ONE 2016 DOI:10.1371/journal.pone.0164306 October 6, 2016: 1-14
  2. Das A, Kennedy KJ, Spyropoulos G, Collignon P. Administrative Data has Poor Accuracy for Surveillance of Staphylococcus aureus bacteraemia. Infection Disease and Health 2016; 21: 162-168.
  3. Fasugba O, Das A, Mnatzaganian G, Mitchell B, Collignon P, Gardner A. Incidence of single-drug-, multidrug-, and extensively drug-antimicrobial resistance of Escherichia coli urinary tract infections: an Australian laboratory-based retrospective study. Journal of Global Antimicrobial Resistance 2019; 16: 254-259.
Dr Gary Lum AM
Dr Gary Lum

Clinical Microbiology
BMedSc[Dist] MBBS FRCPA FACTM FASM

Role:
Honorary Visiting Medical Officer

Areas of Interest:
Public health microbiology and national security
Health emergency management
Poliovirus containment and polio eradication
High containment laboratory biosafety and pathogen security (policy)

Awards:
Appointed a Member of the Order of Australia in 2003 as part of the special Bali Bombing investiture

Important appointments:
Vice President, Royal College of Pathologists of Australasia 2005–2007
Chair, Public Health Laboratory Network 2005–2007
Chair, Board of Proficiency Testing Australia 2005–2007
Chair, Australian Bioterrorism Laboratory Network 2007–present

Contact Details:
Phone (02) 5124 2922
Fax (02) 6244 4646
 

Page last updated on: 12 Sep 2019